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Abstract
The prevalence of hypertension in African Americans is the highest of any population in
the United States, and this population also demonstrates lower rates of adherence to
mediation. Social support and patient–provider communication have been considered as
reinforcing factors to help hypertensive patients achieve optimal blood pressure control.
The purpose of this study was to examine the association of social support and patient–
provider communication and medication adherence for hypertensive African American
men and women. The study was guided by the theory of reasoned action. This study was
conducted to determine whether social support and patient–provider communication was
associated with medication adherence by self-report, age, and gender. A quantitative
cross-sectional design with secondary data analyses was used. The sample included 566
hypertensive African American men and women between the ages of 21and 65 years who
participated in a survey administered in the Counseling African Americans to Control
Hypertension clinical trial collected between 2004 and 2011. The independent variables
were social support and patient–provider communication; the dependent variable was
medication adherence. Descriptive, 2-way analysis of variance and hierarchal logistic
regression model analyses indicated a significant association between patient–provider
communication and medication adherence. There was no significant difference in the
relationship between social support, patient–provider communication, and age and gender
and medication adherence. The implications of this study for social change include
improvement in policies and development programs to support the critical role of
providers in ensuring medication adherence in hypertensive African American patients.
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Section 1: Foundation of the Study and Literature Review
Introduction
Hypertension, also known as high blood pressure, is a chronic disease that affects
people of all ages, races, gender, and ethnic backgrounds. Uncontrolled hypertension
remains an important health issue for patients throughout the United States (Bokhour et
al., 2016). According to the American Heart Association (AHA; 2016), 80 million adults
have been diagnosed with hypertension. Hypertension can also lead to the development
of other health complications including cardiovascular disease, stroke, and kidney disease
(Fongwa et al., 2015; Kretchy, Owusu-Daaku, & Danquah, 2013). In 2010, the mortality
rate indicated that 360,000 American deaths had high blood pressure as a contributing
factor (Brown, 2015). Age, family history, being overweight, a sedentary lifestyle, diet,
and race are factors that increase the risk of an individual developing hypertension
(Centers for Disease Control & Prevention [CDC], 2016).
African American men and women are disproportionality affected by
hypertension. Researchers have shown that the prevalence of hypertension in African
Americans is 42%, which is the highest of any population in the United States (CDC,
2016; Lewis, Ogedegbe, & Ogedegbe, 2012). In addition, African Americans have a
lower rate of adherence to antihypertension mediation (Rimando, 2015). Medication
adherence is defined as “the extent to which patient’s behavior coincides with medical or
health advice, and has been associated with improved health outcomes” (Schmitt, Linder,
& de Santa Helena, 2013, p 615). Nonadherence to medication has also been identified as
a major public health concern, particularly for patients with hypertension. Evidence has
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shown that nonadherence is associated with adverse health outcomes as well as higher
healthcare costs (Nair et al., 2011).
Improving adherence to medication in hypertensive African Americans requires
an understanding of what influences their decision and why nonadherence occurs. Such
barriers that affect adherence rates include cost of medication, socioeconomic status, or a
lack of both social support and patient-provider communication (Rimando, 2015).
Medication adherence is a multidimensional process that can also be influenced by
patients’ health beliefs, knowledge, and attitude (Schoenthaler et al., 2016). For some
African Americans, their intentions on adhering to treatment depend upon what people
think or believe as well as what attitudes they hold and how other people influence them
(Ashaye & Giles, 2003; Rimando, 2015).
Interventions targeted at improving uncontrolled blood pressure in African
American men and women are essential to decreasing morbidity and mortality rates.
Social support and patient-provider communication have been considered as reinforcing
factors to help hypertensive patients achieve optimal blood pressure control (Abel &
Efird, 2013). However, there is a gap of knowledge in understanding how social support
and patient-provider communication are associated with medication adherence among
hypertensive African Americans (Lewis et al., 2012). Through this study, I aimed to
show that improvement in patient-provider communication and social support can help
create social change in African Americans’ attitudes towards self-management of their
health behaviors and reduce patient isolation in dealing with chronic illnesses including
hypertension.
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In the first section of this research study, I will discuss how hypertension among
African Americans is a concern and explain why this study was necessary. I will also
focus on addressing the research questions and the theoretical framework used to support
the study. In Section 1, I will describe the literature search strategy and review the studies
related to medication adherence, social support, and patient-provider communication
based on an in-depth literature review. Lastly, I will define key terms and provide a brief
description of the assumptions and delimitations that could affect the research.
Problem Statement
It is estimated that 30%–50% of hypertensive patients withdraw from their
prescribed medication within 1 year, and 33% of hypertensive patients do not adhere to
the prescribed pharmacologic dosage (Bosworth et al., 2011; Branham, Moose, & Ferreri,
2010). A lack of effective health provider response to uncontrolled blood pressure and
insufficient patient adherence to treatment recommendations create a problem for
hypertensive individuals to maintain their blood pressure. Within the United States, the
prevalence of hypertension is 46% among African American women and 43% among
African American men (Cuffee et al., 2013; Pettey et al., 2016). African American
women with high blood pressure tend to be more aware of their condition and likely to
seek treatment (Flack et al., 2010). They also have relatively higher control rates than
their male counterparts (Ashaye & Giles, 2003).
Nevertheless, enhancing medication adherence in hypertensive African
Americans can be challenging because poor adherence is a multifactorial problem. For
some African Americans, low socioeconomic conditions, including poverty, high stress
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levels, sedentary lifestyles, poor food choices, and lack of physical activity, play a role in
blood pressure control and medication adherence (Forsyth, Schoenthaler, Ogedegbe, &
Ravenell, 2014; Pettey et al., 2016). Both African American men and women are less
likely compared to European Americans to adhere to high blood pressure treatment due
to a lack of health insurance, cost of medication, no access to healthcare, or missed
diagnosis (Lewis, 2012). Additional factors for nonadherence include low education as
well as low health literacy; therefore, many patients lack the knowledge about the
potential health risks and consequences of not taking their medication (Pettey et al.,
2016). Forgetting has also been found to be the most common reason for diagnosed
patients not taking medication (Hill, Miller, & DeGeest, 2011).
Adherence to medical treatment refers to how well and consistently a patient
follows the management plan developed by their healthcare provider (Fongwa et al.,
2008). The consequences of nonadherence to medication can result in poor health
outcomes and increased medical care cost (Fongwa et al., 2008). Education in managing
high blood pressure and medication adherence are needed to improve control rates
(Brunton, 2011; Zullig, Peterson, & Bosworth, 2013).
There is a lack of agreement in literature as to the role social support and patientprovider communication has on African Americans with hypertension (Cornwell &
Waite, 2012; Lewis et al., 2012). Social support is defined as a perceived or actual
instrumental and expressive provision supplied by the community, social networks, and
confiding partners (Holt et al., 2014; Zimet, Dahlem, Zimet, & Farley, 1988). Social
support has been shown to be associated with various health behaviors but has not yet
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been clearly proven to be associated with medication adherence in African Americans
who are diagnosed with hypertension (Lewis et al., 2012; Vaccaro, Exebio, Zarini, &
Huffman, 2014). Likewise, empirical researchers have demonstrated that effective
patient-provider communication can also improve health behaviors through collaboration
between the patient and health provider (Brewer et al., 2013; Schoenthaler, Allegrante,
Chaplin, & Ogedegbe, 2012). There is a lack of understanding, however, regarding the
relationship between patient-provider communication and the attitudes of adherence
towards high blood pressure treatment among African Americans (Lewis et al., 2012).
Therefore, further research was necessary to better understand how social support and
patient-provider communication influence the attitudes of both hypertensive African
American men and women towards medication adherence based on age and gender.
Purpose of Study
The purpose of this quantitative study was to examine the association of social
support and patient-provider communication towards medication adherence for both
hypertensive African American men and women between the ages of 21 and 65 years old
in the United States. Older individuals have been found to be more likely to adhere to
medication in comparison to younger people. Grant et al. (2015) conducted a study on the
effects of expectation of care, perceived social support, and hypertension knowledge,
finding age to be a significant factor in medication adherence among older African
Americans.
The first independent variable in this study was social support, which I defined as
support perceived or received from family, friends, health providers, faith and community
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organizations, and social networking groups or programs that specifically help
hypertensive individuals. The construct of social support can be measured in two
different ways—perceived or received support—utilizing dimensions such as emotional,
instrumental, and informational support (Gallant, 2003). Emotional support is associated
with sharing life experiences, while informational support focuses on the provision of
advice, suggestions, and information that a person can use to address problems (Strom &
Egede, 2012). Instrumental support involves tangible help or services that directly assist a
person in need and is provided by close friends, neighbors, or colleagues (University of
Twente, 2010). The second independent variable was patient-provider communication,
which was defined as patients’ perception of their provider and the clarity of advice given
to them. Patient-provider communication can be measured by assessing patients’
experience of care or the degree to which their doctor provides information (Levinson,
Lesser, & Epstein, 2010).
The dependent variable was adherence to high blood pressure medication, which I
defined as how well and consistently a patient follows recommended treatment and the
plan developed by his or her healthcare provider. The control variables were gender, age,
income, education, employment, insurance status, and place of residence. The length of
time in treatment, number of medications, and the severity of hypertension were also
used as control variables. These demographic variables were used as baseline
characteristics to assess the population under study (see Forsyth et al., 2014; Pettey et al.,
2016).
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Research Questions and Hypotheses
In this research study, I aimed to answer the following research questions by
evaluating their associated hypotheses:
Research Question 1: Are social support and patient-provider communication
associated with hypertensive African Americans self-reported medication
adherence?
H01: There is no significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
H11: There is a significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
I expected that there would be greater adherence to treatment by African Americans with
higher social support and patient-provider communication.
Research Question 2: What is the association between social support and patientprovider communication by age among hypertensive African Americans?
H02: There is no significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
H12: There is a significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
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I expected that there would be greater adherence to treatment for older African
Americans with higher patient-provider communication and social support.
Research Question 3: What is the association between social support and patientprovider communication among hypertensive African American men and women?
H03: There is no significant difference in adherence to medication between
hypertensive African American men and women with or without patientprovider communication and social support.
H13: There is a significant difference in adherence to medication between
hypertensive African American men and women with or without patientprovider communication and social support.
I expected that there would be greater adherence to treatment for African American
women compared to men with higher patient-provider communication and social support.
Theoretical Framework
I used the theory of reasoned action (TRA) of Ajzen and Fishbein (1969; 1980) as
the theoretical framework for this study. This theory is focused on the constructs of
attitude, subjective norms and perceived control, which can be used to help explain the
variance in behavioral intention (Glanz, Rimer, & Viswanath, 2015). Attitudes can be
based on multiple factors, including past experiences, social support, health education
and literacy, and the environment (Cleverism, 2018; Hackman & Knowlden, 2014).
Subjective norms are considered the beliefs an individual has regarding whether others
approve or disapprove of the behavior and the motivation to comply (RECAPP, 2016).
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The TRA is further concerned with the individual motivational factors as determinants of
the likelihood of performing a specific behavior (Hackman & Knowlden, 2014).
I used this theoretical construct in order to better understand how social support
and patient-provider communication influence or motivate hypertensive African
Americans to adhere to medication. The TRA has eight key constructs, which include
behavior, behavioral intention, attitude, behavioral belief, evaluation, subjective norm,
normative beliefs, and motivation to comply (Glanz et al., 2015). The more positive the
attitude and subjective norms, the greater the perceived control and the more likely an
individual is to comply with the intended behavior (RECAPP, 2016). The individual must
decide to adhere to treatment in order to reduce other associated health risks. A strength
of the TRA is that the framework provides a way to identify and measure the underlying
reasons why a person intends to behave a particular way (RECAPP, 2016). If patients’
attitudes change over time through social support or patient-provider communication,
then their behavioral intent would most likely change as well.
Nature of Study
In this study, I used the quantitative approach with a cross-sectional design.
Quantitative research is a method that tests the objective theories by examining the
relationship between the independent and dependent variables, and the data analysis is
constrained by the type of data available (Creswell, 2009). In a quantitative approach,
numerical data are gathered and used to generalize across a particular group of people to
explain a particular phenomenon (University of Southern California, 2016). Moreover,
the cross-sectional design was most appropriate for this study because I aimed to

10
determine the association between the independent and dependent variables at a single
point in time (see Creswell, 2009). The cross-sectional design is observational and allows
for multiple variables to be compared at the same time (Cherry, 2015). The key variables
in this study were social support and patient-provider communication as the independent
variables and medication adherence as the dependent variable. The covariates were
gender, age, income, education, employment, insurance status, place of residence, the
length of time in treatment, number of medications, and the severity of hypertension.
Secondary Data Set
I used a secondary data set to collect cross-sectional data for this study. Secondary
data describes the analysis of larger data sets collected by a primary source, which allows
studies to be conducted on high-impact research questions to further help improve the
understanding of a public health issue (Smith et al., 2011). Likewise, secondary data are
useful when time and resources are limited to design questionnaires and manage a largescale data collection project (Cheng & Phillips, 2014). One of the main goals of
quantitative research is the concept of external validity, which involves generalizing the
research results to a larger population (Laerd Statistics, 2012). External validity can be
increased if the study is properly designed and there is a good representation of the
population under study (Rothwell, 2006; Steckler & McLeroy, 2008).
Literature Search Strategy
I conducted a literature search for peer-reviewed journal articles to review
empirical studies with data-based conclusions relevant to the research questions of this
study. I searched Walden University’s data library, published dissertations, ProQuest,
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PubMed, and Medline. The CDC data library and Google Scholar were also used to
obtain relevant information on hypertension and medication adherence. Only peerreviewed journal articles published within the last 5 to 6 years were used for this research
study. Due to limited data based on current research, I also considered peer-reviewed
journals published within the last 9 years as relevant sources for this study if they had
been referenced in other research studies.
I used the following key search terms: hypertension, medication adherence,
African Americans, high blood pressure, social support, and patient-provider
communication. My search yielded over 100 sources in the area of hypertension,
medication adherence, and African Americans. I reviewed over 80 articles that addressed
the influences of patient-provider communication and social support on medication
adherence in individuals diagnosed with hypertension and what has been shown to hinder
or facilitate improvement blood pressure control among the target population.
Literature Review
Overview of Hypertension
Hypertension, or high blood pressure, is a chronic condition that has a significant
impact on health outcomes and health disparities (Guo, He, Zhang, & Walton, 2012).
Hypertension exists when blood pressure is 140/90 millimeters of mercury (mmHg) or
above most of the time (AHA, 2016). When the force of the blood flow is high, the walls
of the arteries become stretched beyond a healthy limit, causing damage (AHA, 2016).
According to the World Health Organization (WHO; 2016), hypertension contributes to
9.4 million deaths worldwide every year. Economically, the burden of hypertension is
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around $47.5 billion annually in direct medical expenses and $3.5 billion in lost
productivity (Rajpura & Nayak, 2014).
According to data from the National Health and Nutrition Examination Survey, 1
in every 3 adults in the United States aged 20 years or older suffer from hypertension
(Rajpura & Nayak, 2014). While hypertension is a modifiable condition, if left untreated,
it can lead to numerous health problems including heart disease, stroke, kidney failure,
and vision loss (AHA, 2016). This condition must be detected early and treated
appropriately in order to avoid poor health outcomes. Adherence to treatment is the
foundation to helping control blood pressure.
Prevalence of Hypertension Among African Americans
The health status for African Americans in the United States lags behind that of
other racial and ethnic groups (Martin et al., 2011). Many African Americans report a
lack of confidence in the healthcare system, and some hold the belief that they are less
likely to receive the same medical resources and quality of care as European Americans
(Martin et al., 2011). Additionally, because African Americans are disproportionately
affected by high blood pressure, the prevalence of hypertension is much higher for this
population in comparison to European Americans or Hispanics (Lewis et al., 2012). Heart
disease is a contributing factor for hypertension and further contributes to the morbidity
and mortality in African Americans (Brown, 2015). The onset of hypertension tends to
develop at an earlier age for African Americans, and its symptoms are usually more
severe (CDC, 2016). Various barriers have caused an increase in the incidence of
uncontrolled high blood pressure for African Americans including poverty,
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socioeconomic status, access to medical care, a lack of health insurance, and
nonadherence to treatment (Grant et al., 2015).
Researchers have reported that 45% of African American men and 46% of
African American women have hypertension, in comparison to 34% of European
American men and 31% of European American women (CDC, 2016; Pettey et al., 2016).
The National Health and Nutrition Examination Survey reported that only about 28% of
African Americans with high blood pressure have it under controlled in comparison to
33% of European Americans (Fauntleroy, 2013). Moreover, there is a greater risk of
being diagnosed with hypertension for African Americans living in the South (Pettey et
al., 2016). Similarly, Martin et al. (2011) found that rural African American residents had
the worse blood pressure control in comparison to their rural and urban White
counterparts. Even with access to free medication and a regular source of healthcare,
rural or low-income hypertensive African American residents continue to encounter
medication adherence barriers (Martin et al., 2011).
Medication Adherence and Nonadherence
Medications continue to be beneficial in saving lives for many individuals
diagnosed with a chronic illness. Adherence to medication is an essential component of
successful patient care and self-management of hypertension (Bosworth et al., 2011).
Hypertensive patients are often encouraged to establish a consistent medication routine in
their daily lives to increase adherence behaviors and to achieve optimal high blood
pressure control rates (Solomon et al., 2015). Nonadherence to medication or treatment
for high blood pressure is complex and challenging due to medication costs, health
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literacy, older age, a complex routine regimen, as well as poor social support and patientprovider communication (Marshal, Wolfe, & McKevitt, 2012).
Nonadherence is often an unrecognized risk factor that further contributes to a
lack of control of blood pressure for individuals diagnosed with hypertension (OliveiraFilho, Barreto-Filho, Neves, & Lyra Junior, 2012). Researchers have estimated that 20%
to 50% of patients do not take their medication as prescribed (Oliveira-Filho et al., 2012).
It has also been estimated that 125,000 deaths occur in the United States annually due to
nonadherence to medication (Bosworth et al., 2011). Although medication adherence is a
behavior in which people should be able to report, there has been a lack of adequate
reliability and strong validity in self-report measures of medication adherence (Morisky
& DiMatteo, 2011).
Moreover, nonadherence can be categorized as intentional or unintentional if the
given treatment advice is ignored, misunderstood, or used incorrectly (Miller &
DiMatteo, 2013). Nair et al. (2011) conducted a qualitative study to understand the
barriers that influenced adherence rates for hypertensive patients and found that
unintentional nonadherence, which included forgetfulness or a lack of access to
medications, was the primary form of nonadherence for patients with high blood
pressure. When patients perceive that the prescribed medication is not working or has
unwanted side effects, they may stop taking the treatment, which would be considered
intentional nonadherence (Pettey et al., 2016; Schmitt et al., 2013). Schoenthaler, Butler,
Chaplin, Tobin, and Ogedegbe (2016) conducted a cross-sectional study to examine the
predictive role of key psychosocial and interpersonal factors on changes in medication

15
adherence in hypertensive African American patients. These researchers concluded that
both patient-provider communication and social support indirectly affected medication
adherence among patients; yet, efforts were still needed to improve adherence behaviors
based on the patient’s medical care and the community they resided in.
Assessment of medication adherence among African Americans. High blood
pressure continues to increase among African Americans, and medication adherence rates
are much lower for those who have been diagnosed with hypertension (Lewis, 2012).
Studies have shown that antihypertensive medications have an impact on achieving
optimal blood pressure control; yet, nonadherence to treatment has also been identified as
a reason for poorly controlled blood pressure among African Americans (Hu, Taira,
Yeboah, & Castillo, 2014). Conversely, documenting the adherence rates among
hypertensive patients has been found to be difficult, and it is still not clear as to the
factors that are associated with adherence for African Americans (Lewis, 2012). Barriers
that affect African Americans from seeking proper treatment include poverty, lowincome, stress, religious practices, and cultural beliefs and attitudes (Brown, 2015).
Misperceptions and a lack of understanding of the causes and treatment greatly
influence medication adherence as well (Buis, Artinian, Schwiebert, Yarandi, & Levy,
2014). Thus, it is imperative for African Americans diagnosed with hypertension to
adhere to treatment to help lower the burden of heart disease morbidity and mortality and
improve their blood pressure control. It is also important for healthcare providers to
understand the culture of African Americans, and tailor treatment based on the particular
needs of the patient (Brown, 2015).
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Adherence among African American men and women. Poor adherence to
antihypertensive medications is more pronounced in African American men than in
women (Lewis, Schoenthaler, & Ogedegbe, 2012). African American women tend to
have a greater awareness of their condition and are quicker to seek treatment, and
therefore, exhibit better blood pressure control rates (Ashaye & Giles, 2003). Through a
literature review, Lewis et al. (2012) showed that higher rates of medication
nonadherence existed for African American men even in environments with equal access
to care regardless of race or socioeconomic status. In another literature review examining
factors associated with medication adherence among hypertensive African Americans,
Lewis (2012) found that men were more likely to be nonadherent to their
antihypertensive medications in comparison to women. On the other hand, Petty et al.
(2012) found that females were less adherent to treatment than men due to a higher
amount of medication and neglecting to take care. Rose, Kim, Dennison, and Hill (2000)
conducted a qualitative study on the contexts of adherence for African Americans
between the ages of 18 and 49 years old with high blood pressure and concluded that it
was important for African American men to have a collaborative relationship with their
healthcare provider, which also had a significant positive influence on their adherence to
recommended medications. Additional researchers have shown that there is no
association between gender and medication adherence (Lewis, 2012). These studies,
however, were limited due to the use of self-reported data as well as a delimitation of
only male participants.
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Older Age and Hypertension
Older adults may seemingly be faced with a greater challenge of adhering to
recommended treatment when diagnosed with a chronic disease. The risk for
hypertension increases as an individual becomes older (Holt et al., 2014). Schmitt et al.
(2013) stated that older adults represented about 50% of multidrug users due to the
prevalence of chronic illnesses. According to the CDC (2016), men under the age of 45
years old are more highly affected by hypertension than women, while women over the
age of 65 years old are more affected by high blood pressure than men. Researchers have
shown that an estimated 40% of adults between the ages of 45 and 64 years old and
adults over the age of 65 years old have hypertension (Warren-Findlow, Seymour, &
Huber, 2012). Although older adults who are diagnosed with hypertension tend to have
better control rates than younger adults, less than 50% of them have it under control
(Cornwell & Waite, 2012; Guo et al., 2012).
In particular, rates of uncontrolled hypertension are higher for African American
older adults (Cornwell & Waite, 2012). In a study on adherence behaviors among
hypertensive African Americans followed in primary care clinics, Hekler et al. (2008)
reported that older age was associated with better medication adherence; however,
scholars have shown that age does not predict or influence medication adherence for
hypertension patients. For example, Nair et al. (2011) found that differences in age did
not appear to influence nonadherence or predict adherence reliably. Nonetheless, the
results of this study were limited because the authors did not compare hypertensive
patients with high adherence rates to those patients with low or moderate adherence.
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Similarly, in a meta-analysis examining the association between age and medication
adherence among hypertensive African Americans, the results did not show an
association while the findings of four cross-sectional studies included in the metaanalysis demonstrated an association between age and adherence (Lewis, 2012). Zullig et
al. (2015) also conducted a cross-sectional analysis on self-reported medication
adherence, race, and patient-provider communication and found that older African
Americans reported following their health providers recommended instructions on
medications less frequently than older European American patients.
Attitudes Towards Medication Adherence
Patients’ beliefs and attitudes towards medication have been shown to be
important drivers for adherence and disease outcomes in adults (Martin et al., 2011). As
previously mentioned, barriers to treatment adherence include the effectiveness of the
medication, cultural perceptions and attitude, amount of social support, and the level of
patient-provider communication (AlGhurair, Hughes, Simpson, & Guirguis, 2012).
Pettey et al. (2016) stated that understanding the perceptions of medication adherence and
lifestyle changes needed to treat high blood pressure could further help to provide a
foundation for improving adherence rates among African Americans. Few empirical
studies have focused on the perceptions of adherence to treatment among hypertensive
African Americans. In a literature review on medication adherence in hypertensive
African Americans, Lewis (2012) found that attitudes and illness beliefs did not have a
significant association with medication adherence. Nonetheless, this result may have been
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due to the limited number of extant studies found by the author and the majority being
cross-sectional.
Pettey et al. (2016) conducted a qualitative study to examine the perceptions of
hypertensive treatment among African Americans between the ages of 21 and 64 years
old. These investigators found that many of the participants had a willingness to adhere to
their treatment but found it difficult even with free access to healthcare. Their study was
limited by potential sample bias and longitudinal data that were not yet available at the
time of analysis of their health because they focused on taking care of others (Pettey et
al., 2016). Hardeman et al. (2015) conducted a quantitative study to examine the attitudes
toward patient-centered care among African American and European American first year
medical students. They conducted an assessment of the association between race, gender,
and socioeconomic status with attitudes towards patient-centered care. The researchers
concluded that status as a female medical student and a student with a low- to middleincome socioeconomic background significantly impacted their attitudes towards patientcentered care. Additionally, older medical students over the age of 25 also had more
positive attitudes towards patient-centered care; however, race had no significant impact
on their attitudes towards the topic (Hardeman et al., 2015).
Effects of Social Support
Social support plays a vital role in promoting better health outcomes and
alleviating chronic diseases such as hypertension (Nurullah, 2012). According to Hatah et
al. (2015), greater levels of social support are associated with better treatment adherence.
Social support can come in the form of friends, family, coworkers, healthcare providers,
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or community and faith-based organizations as perceived or received support. The
concept of social support evaluates the interpersonal communication and relationships
and support a patient receives from peers and medical providers (Criswell, Weber, Xu, &
Carter, 2010). A person’s perception of social support is usually reflected by the specific
behaviors of family and peers, which can have positive or negative effects on adherence
to treatment (Rosland, Heisler, & Piette, 2012). Additionally, social support is useful for
increasing patients’ perception regarding quality of life, facilitating better access to
medical resources and utilization of healthcare services, as well as improving selfmanagement of hypertension. Social support from family members provides patients with
practical help and can buffer the stresses of living with an illness (Miller & DiMatteo,
2013).
Empirical investigators have used three broad categories to measure social
support: social connectedness, perceived social support, and actual social support (Kim et
al., 2015). The most common ways to measure social support include emotional,
instrumental, and information support. Emotional support is defined as an individual
having another person in his or her life to provide empathy, and someone that can be
trusted (Johnson, Jacobson, Gazmararian, & Blake, 2010). Informational support
describes having someone to help with reading written materials obtained from a
physician or hospital. Moreover, instrumental support, also known as tangible support,
includes the provision of material aid such as giving information to understand a situation
or someone helping an individual complete their chores is they are sick (Johnson et al.,
2010).
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In a systematic review conducted on the impact of family behaviors and
communication patterns on chronic illness outcomes, the results found that family
encouragement and cohesion were associated with improved outcomes for individuals
diagnosed with hypertension (Rosland et al., 2012). These researchers also found that
general social support had a stronger effect for women than men. Moreover, Schoenthaler
et al. (2016) found that functional social support rather than structural social support was
an important aspect to adherence of antihypertensive medications. In a qualitative study
conducted by Petty et al. (2016), 53% of the respondents reported that family support
such as a mother or sister, was the most important, as well as hearing stories about family
and friends with certain health complications facilitated their decision to seek care or
adhere to treatment.
Studies have also been conducted to show the effects of culture and religion on
social support and medication adherence. African Americans tend to have higher levels
of religious involvement, and church is usually the foundation of the community (Holt et
al., 2014). Religious involvement is a way to facilitate social support and provide a sense
of belonging, as well as, cohesiveness. In the cross-sectional study conducted by Hatah et
al. (2015), the researchers evaluated the influence of cultural orientation and religiosity of
patients with chronic diseases including hypertension on social support and adherence to
medication. The researchers found that while age, duration of treatment, and faith-based
activity had significant influence on adherence to treatment, there was no significant
association between social support and medication adherence. Holt et al. (2014)
performed a qualitative study to assess the role of social support and the relationship of
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religious involvement and physical and emotional functioning among African Americans
and health outcomes. Holt et al. concluded that tangible social support was associated
with religious behaviors and improving medication adherence.
The impact of social support can influence the ability of an individual to make
lifestyle adjustments that would help them to live with hypertension and make positive
behavioral changes. A randomized clinical trial was conducted by Bokhour et al. (2016)
to assess the impact of viewing African American patients’ stories of successfully
controlling hypertension on intention to change self-management behaviors, as well as,
engagement with educational materials. The study sample included 618 African
American veterans with uncontrolled blood pressure who viewed information-only DVDs
about hypertension or a DVD with African American veterans telling stories about
successfully managing their blood pressure. The results demonstrated that videotaped
patient’s stories was not only an effective way of communication but also influenced
other hypertensive patient’s intentions to change their health behaviors affecting blood
pressure control (Bokhour et al., 2016). The use of story sharing was a way to increase
social support and peer interventions that could further help patients adhere to their
medications. These authors also found that patients were more likely to communicate
with their doctors after viewing the stories (Bokhour et al., 2016). Nevertheless, the study
was limited to focusing on patients’ intention to change their health behaviors but may
not have resulted in actual change.
Social support through family and community members has been shown to be
influential in African Americans decisions to adherence to hypertensive treatment; yet,
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the extent of this influence is still not completely understood (Pettey et al. 2016). Social
support can have a negative impact and become a barrier to self-management of
hypertension. For example, in a literature review conducted by Miller and DiMatteo
(2013), the investigators found that social support had been linked to adverse health
outcomes and suggested that some patients felt criticized, nagged, or guilty when
receiving support from family. The sabotaging behavior created conflict due to an
increase in family involvement and undermined the success of an individual adhering to
medication. Lewis et al. (2012) also found that social support did not appear to be
consistently associated with medication adherence in hypertensive African Americans.
Braverman and Dedier (2009) used an electronic cap to measure medication adherence
and found that social support was not associated with adherence.
Patient-Provider Communication and Care
Communication skills are fundamental in healthcare, in particular between the
provider and the patient. Patient-provider communication is multidimensional and can
have an impact on patients’ decision to adhere to their medication (Levinson et al., 2010;
Schoenthaler et al., 2009). Patients tend to rely on their healthcare provider as the
primary source of information when discussing medical care and treatment options
(Lewis et al., 2012). The provider usually asks the patient various questions to assess the
best medical treatment that would meet patients’ needs for their particular health
condition such as hypertension. Patients who communicate with their healthcare provider
have the ability to express how they feel about their health, medical treatment, and
making healthier lifestyle choices; however, healthcare providers have been found to lack
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skills in identifying poor medication adherence among their African American patients.
For example, in a study about young, urban hypertensive African Americans, the authors
estimated that 60% of the time, the health provider was unable to identify poor mediation
adherence (Braverman & Dedier, 2009).
Moreover, trust in a provider is synonymous with adherence to treatment. Patientprovider communication is one way to establish trust and encourage individuals to
become more involved in decisions regarding their health (Martin et al., 2011). Equally,
the trust built through patient-provider communication can be associated with better
satisfaction with healthcare, an increase in treatment adherence, as well as, improved
health outcomes. Abel and Efird (2013) stated that patients’ trust in their health provider
implies confidence that the provider’s words are honest, and actions are appropriate in the
provision of care and treatment. Lower levels of trust in health providers are also
associated with lower patient satisfaction and treatment adherence among racial minority
populations, including African Americans (Martin et al., 2011).
African Americans are less likely to seek or receive needed health services,
procedures, or routine treatments for hypertension in comparison to White Americans
(Martin et al., 2011). Researchers have further suggested that African American patients
report poor quality of interactions with healthcare providers (Greer, Brondolo, & Brown,
2014). Abel and Efird (2013) found that hypertensive African American women who
trusted their health providers were more likely to be adherent to treatment versus those
who did not trust their providers. The lack of trust and communication can also increase
health disparities among races. The distrustful relationships between African Americans
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and healthcare providers have also been influenced by past historical events such as the
Tuskegee experiment. Throughout history, African Americans were frequently used in
experiments by White doctors to help improve medical and surgical techniques before
attempting the same procedures on Whites, thus causing distrust (Abel & Efird, 2013).
Likewise, patients who engage in decision-making with their healthcare provider
are not only more likely to be satisfied with the quality of care but are also likely to
adhere to recommended treatment (Aseltine, Sabina, Barclay, & Graham, 2016;
Schoenthaler et al., 2009). Several barriers, however, interfere with adherence to
hypertensive treatment including a lack of knowledge and understanding of a provider’s
recommendations. Patient-provider communication can also be a complex process due to
unrealistic patient expectations, nondisclosure of information, or a lack of sensitivity for
the patient (Schoenthaler et al., 2012). Furthermore, healthcare providers are unable to
accurately assess their patients’ perceptions of their care, what is important to them, nor
how well the care is being delivered (Rickert, 2012).
Similarly, African American patients may receive marked differences in the
quality of patient-provider communication due to their race (Aseltine et al., 2016). Thus,
racial differences also create a barrier to patient-provider communication. For instance,
reports have shown that hypertensive African American patients receive suboptimal
communication with providers and higher levels of unmet information needs (Lewis et
al., 2012). In comparison to White Americans, communication for some African
American patients was less informative and supportive, as well as, less participatory.
Some healthcare providers perceived hypertensive African American patients as less
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effective communicators, treated them contentiously, and did not use patient-centered
communication. On the other hand, African American patients perceived their provider as
disrespectful and provided unfair treatment, thus leading to a decrease in using health
services and adherence to treatment.
Three main goals of patient-provider communication include developing an
interpersonal relationship, facilitating the exchange of information, and involving patients
in decisions making (Ha, Anat, & Longnecker, 2010). Miscommunication, however, can
cause complications between the patient and healthcare provider that could hinder
patients’ understanding, expectations of treatment, or involvement in the medical
decisions. Miscommunication also decreases patients’ satisfaction with the quality of
medical care (Ha et al., 2010). Doctors who avoid discussing patients’ problems or
discourage patients from voicing their concerns are additional barriers to medication
adherence and patient-provider communication.
According to the Agency for Healthcare Research and Quality (2014), 40%–80%
of the medical information patients are given during an office visit is forgotten
immediately or nearly half of the information retained is incorrect. Patients who lack a
clear understanding of their health condition will more than likely not make a follow-up
appointment or risk being readmitted to the hospital. Collaborative patient-provider
communication increases the likelihood of a patient adhering to their antihypertensive
medication, especially for African Americans (Schoenthaler et al., 2016). The process of
communication can significantly depend on preexisting, shared cultural patterns, and
social structures (Lewis et al., 2012). Like social support, the role and influence of
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patient-provider communication is not clearly understood among African American
hypertensive patients (Schoenthaler et al., 2016).
Definition of Terms
Hypertension: This is a term used to describe high blood pressure (Rajpura &
Nayak, 2014).
Medication adherence: The extent to which a patient follows a given medication
regimen as agreed on in partnership with a healthcare professional (AlGhurair, Hughes,
Simpson, & Guirguis, 2012)
Medication nonadherence: The extent to which patients do not follow treatment
recommendations given by their health providers, either willfully or inadvertently (Miller
& DiMatteo, 2013; Rajpura & Nayak, 2014).
Patient-provider communication: An increase in health providers’ understanding
of patients’ individual values, needs, and perspectives that allows patients to actively
participate in decisions regarding their health and healthcare (Levinson et al., 2010;
Zulling et al., 2015).
Social support: The exchange of resources between two individuals perceived by
the provider or the recipient to be intended to enhance the well-being of the recipient;
assets that an individual is provided through their social ties (Hatah et al., 2015; Holt et
al., 2014).
Uncontrolled blood pressure: A persistent elevation of systolic blood pressure of
140 mmHg or higher and diastolic blood pressure of 90 mmHg or higher (Grant et al.,
2015).
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Assumptions
I assumed that participants self-identified as African American. I also assumed
that participants truthfully answered questionnaires to the best of their ability and on their
own. Finally, I assumed that the material presented in the surveys was understood and
relevant to the participants’ life condition.
Scope and Delimitations
It was within the scope of this doctoral study to address the significance of
patient-provider communication and social support on the influence of attitudes towards
medication adherence in hypertensive African American patients. Poorly controlled
hypertension due to nonadherence to antihypertensive medication continues to remain a
significant public health issue in the United States, and specifically among African
Americans (Schoenthaler et al., 2012). The study was delimited to African American men
and women between the ages of 21–65 years, born in the United States, who speak fluent
English, and have at minimum a high school education. Participants were required to be
diagnosed with hypertension and were required to be taking at least one antihypertensive
medication. Participants had to self-identify as African American. A secondary data set
was used to collect information on selected participants related to the measuring variables
for this study. By using secondary data, the quality of data, data collection, and available
measuring instruments was limited to what was obtained in the primary research study.
Significance of Social Change Implications
Adherence to hypertension treatment is essential to controlling blood pressure as
well as decreasing other health complications. Medication adherence is significantly
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important for African Americans because they have a disproportionately greater burden
of cardiovascular disease morbidity and mortality rates than any other ethnic group in the
United States (Solomon et al., 2015). Thus, there is a need for enhanced patient-provider
communication so that African Americans can learn to properly manage their blood
pressure (Solomon et al., 2015). Treatment can then be tailored to meet the particular
needs of patients based on their level of health knowledge.
Likewise, through social support, the creation of effective support groups can
develop positive change by helping to promote adherence to medication and healthy
living (Vaccaro et al., 2014). It is imperative for the healthcare community to identify
barriers to medication adherence and develop efficient ways to engage African American
men and women in programs to improve their hypertension control (Nair et al., 2011).
Improvement of hypertension-related knowledge is an important strategy for increasing
medication adherence (Zulling et al., 2013); however, no particular intervention for
improving medication adherence in hypertensive individuals has emerged as the universal
standard for improvement. (Lewis et al., 2012).
There is still a need to identify strategies to sustain adherence over time and create
social change in health behaviors of African Americans with uncontrolled blood pressure
(Lewis et al., 2012). The findings of this study could provide insight for healthcare
providers to improve patient-provider communication among hypertensive African
Americans by adapting better cultural sensitivity, which can help improve the attitudes
towards self-management of health behaviors. This may also lead to an increase in better
health outcomes and reduce chronic illnesses, hospitalizations, and associated diseases

30
(Aseltine et al., 2016). Furthermore, the results of this study could provide an
understanding on how the impact of social support, through family, friends, and
community sources can help prevent patient isolation in dealing with chronic health
conditions. Thus, hypertensive African Americans could establish a more positive
attitude about their health and develop better adherence to recommended treatment.
Conclusion
In Section 1, I illustrated how TRA was used as a foundation for this research
investigation. In Section 1, I also provided an outline regarding the high prevalence of
hypertension among African American men and women and why it has become a public
health concern. Previous scholars have shown the importance of adhering to medication
to improve health outcomes for patients diagnosed with hypertension. African Americans
continue to be disproportionately affected by high rates of uncontrolled blood pressure
and have lower rates of medication adherence. Patient-provider communication and
social support are necessary factors to help improve blood pressure control and rates of
adherence to medication among hypertensive African Americans; yet, studies are limited,
have been inconclusive, or have varied according to gender and age in understanding the
influence social support and patient-provider communication have on the attitudes of
hypertensive patients towards medication adherence. Therefore, further research is
warranted to obtain these findings. In Section 2, I will describe the research design and
rationale of the doctoral study, including a brief description of the secondary data set that
I used to collect data for analyzation. I will also discuss the methodology, including
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sampling, setting, sampling frame, data collection, and the variable measuring
instruments.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this doctoral study was to examine the association between social
support and patient-provider communication towards medication adherence for both
hypertensive African American men and women between the ages of 21 and 65 years old
in the United States. This section will include an overview of the quantitative crosssectional design of the study, the rationale for choosing such a design, and the sampling
method used. In Section 2, I will also discuss the sampling frame, the methods used for
data collection, and the variable measuring instruments. Furthermore, I will briefly
describe the Counseling African Americans to Control Hypertension (CAATCH) clinical
trial study from which the secondary data were obtained. Data from the CAATCH study
were collected between 2004 and 2011. Finally, I will describe the data analysis
procedures, threats to internal and external validities, and ethical considerations of the
study.
Research Design and Rationale
I used a quantitative cross-sectional design with a secondary data analysis as the
approach for this study. In a cross-sectional study, data are collected at a single point in
time to examine the relationship between the disease, such as hypertension, and other
variables of interest (Cherry, 2015). Additionally, a cross-sectional study can provide a
snapshot of various health-related characteristics or frequency of a disease for a defined
population. An advantage to conducting a cross-sectional study is that information can be
gathered quickly and in a less expensive manner than other designs (Cherry, 2015). A
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cross-sectional study allows multiple factors, including exposure, outcomes, and
confounders, to be examined simultaneously (Cherry, 2015). Moreover, I used a
secondary data set that contained the variables and measuring instruments related to this
doctoral study. It was not my goal to interview or observe participants in their natural
setting. Likewise, due to time constraints in designing the study and collecting primary
data, use of a secondary data set was appropriate for this study.
Study Variables
The design that I chose for this study allowed for the assessment of the
relationship between the independent and dependent variables. I focused on two
independent or predictive variables, which were patient-provider communication and
social support. The dependent or outcome variable was medication adherence among
hypertensive African Americans. The covariate variables included gender, age, income,
education, employment, insurance status, and place of residence. The length of time in
treatment, number of medications, and the severity of hypertension were also used as
moderating variables. Using these particular demographics allowed me to generalize the
findings to a broader population (see Ogedegbe et al., 2014).
Methodology
Population
The target population for this doctoral study was hypertensive African American
men and women between the ages of 21 and 65 years old. A total of 1,039 patients over
the age of 18 years old were enrolled in the study who self-identified as African
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American with uncontrolled hypertension (Ogedegbe et al., 2014). From this population,
I selected the sample participants.
Setting and Sampling Method
I identified a cluster-randomized clinical trial known as the CAATCH trial as the
appropriate secondary data set to use for this doctoral study. The CAATCH study is
considered the largest, practice-based, implementation trial of a multilevel, evidencebased intervention targeted towards blood pressure control in hypertensive African
Americans and represented the best source of data for this research study (see Ogedegbe
et al., 2014). A total of 1,039 patients over the age of 18 years old were enrolled in the
study who self-identified as African American with uncontrolled hypertension
(Fernandez et al., 2011). The patients were chosen from 30 community health centers
where they received care and randomly assigned to the intervention condition or usual
care condition (Fernandez et al., 2011). Patients were recruited through letters from their
primary care clinicians (Ogedegbe et al., 2014). Random sampling can help to ensure that
every sampling unit of the population has an equal chance of being included in the
sample (Frankfort-Nachmias & Nachmias, 2008). An advantage to using random
sampling is the potential to reduce selection bias (Laerd Statistics, 2012). The CAATCH
study protocol was approved by the institutional review boards of Columbia University,
New York University, and the Clinical Directors Network (Ogedegbe et al., 2014). I
obtained permission to access the data set through an e-mail sent to the original
researchers. A copy of this letter is located in Appendix A.
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Sampling Frame
I determined the sampling frame based on the inclusion and exclusion criteria
from the primary study. Participants who met the original demographic and inclusion
criteria were also eligible for this study. In the following subsections, I will detail these
criteria.
Inclusion. The participants were required to self-identify as African American
and be between the ages of 21 and 65 years old. The participants were required to speak
fluent English and be receiving care at the community health center for more than 6
months. The participants were required to have received a diagnosis of hypertension and
uncontrolled blood pressure since their last office visit. Lastly, the participants were
required to be on at least one antihypertensive medication.
Exclusion. Participants were excluded if they did not speak English and were
unable or unwilling to complete screening or baseline assessment. Participants were also
excluded if they had already participated in a hypertensive clinical study. The participants
could not have an arm circumference greater than 42cm.
Data Collection Method
I collected data for this doctoral study through surveys that were administered
originally in the CAATCH study. A survey is an instrument used to collect verifiable
information, and usually requires a respondent to choose from a scale (Center for
Research Quality, 2015). Surveys are also useful for collecting self-reported information
on hard-to-measure variables. Data and study measurements were previously gathered by
trained research assistants at baseline and every 3 months for 12 months, with a follow-
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up 24 months later (Schoenthaler et al., 2016). Participants for the original study were
recruited via letters from their primary care doctors at community health centers
(Ogedegbe et al., 2014). All enrolled patients provided written informed consent (see
Ogedegbe et al., 2014). I selected participants for this doctoral study from the CAATCH
trial data set based on their responses to sociodemographic data and survey questions
related to the measuring variables of this study. Demographic data included gender, age,
employment status, insurance status, education, and income level. I gained access to the
secondary data set through a permissions e-mail that I sent to the original researchers.
Power Analysis
I used a power analysis in this quantitative research study to help determine the
sample size. Performing a power analysis and sample size calculation is an important
aspect of a research design to avoid the sample size from being too small or too large to
detect any significant differences between groups (Statistic Solutions, 2017). Power
refers to the probability of achieving a significant result if the null hypothesis is false
(UCLA Statistical Consulting Group, 2017). The probability also increases as the sample
size gets larger (McDonald, 2014). Moreover, the statistical power is dependent on the
effect size, which can be small, medium, or large (UCLA Statistical Consulting Group,
2017). For example, larger effect sizes require smaller samples sizes to have the same
power, while smaller effect sizes require larger samples to have enough power (Sullivan
& Feinn, 2012). The most commonly used power level is 0.80, with an alpha of 0.05 to
achieve the desired level of significance (UCLA Statistical Consulting Group, 2017). I
used the G*Power software as the statistical tool to calculate the sample size for this
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doctoral study. I anticipated that a minimum sample size of 248 participants would be
needed to test statistical significance for the study. The sample size was calculated using
binomial logistic regression statistical model with a two-tailed test, an alpha of 0.05, and
0.80 power. The effect size was set to 0.3. Based on these projections, a sample size of
248 was deemed adequate for detecting a medium effect size for Hypotheses 1 and 2.
Instrumentation
Measuring instruments had already been developed and validated within the
original CAATCH trial study, so I tailored these instruments for this research study. The
instruments that I used in this doctoral study included the Morisky Medication Adherence
Scale (MMAS), the Social Support Scale, and the Physician Communication Style
Survey. Table 1 provides a brief summary of the operationalization of variables that I
used in this doctoral study.
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Table 1
Operationalization of Variables
Variable
Adherence
Physician
Communication
Style
Social Support

Covariates

Brief Description
Adherence to prescribed
medication
Patient-provider
communication

Data Category
Binary

Social Support

Continuous

Age

Interval

Gender

Nominal

0 = Male
1 = Female

Marital Status

Ordinal

0 = Never married
1 = Married
2 = Divorced
3 = Separated
4 = Widowed

Education

Ordinal

0 = None
1 = Grades 8
2 = Grade 9
3 = High School
4 = Technical School
5 = Some College
6 = Associates
7 = Bachelors
8 = Graduate School
(Masters or Above)

Employment

Binomial

Income

Ordinal

Insurance

Binomial

Continuous

Measure
0 = Nonadherent
1 = Adherent
Questionnaire (Bultman &
Svarstad, 2000)
Medical Outcomes Study
(MOS) Social Support Survey
(Sherbourne & Stewart, 1991)
21-65

0 = No
1 = Yes
0 = less than $25,000
1 = ≥ $25,000
0 = No
1 = Yes

Morisky Medication Adherence Scale (MMAS)
In this study, I assessed medication adherence using the MMAS, a psychosocial
measure used in the CAATCH trial study. The MMAS is an indirect method of
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measurement, and it includes a structured self-reported questionnaire used to assess the
behavior of medication adherence for patients diagnosed with chronic illnesses, such as
hypertension (Morisky & DiMatteo, 2011). In 2008, the scale was updated to an 8-item
measure (MMAS-8), which has been shown to have high reliability and validity. For
instance, in a study conducted by Oliveira-Filho et al. (2012), the MMAS-8 was used to
measure medication adherence and demonstrated good potential as a screening tool in
clinical practice to identify nonadherent patients and those at risk of uncontrolled blood
pressure. The scale further demonstrated excellent internal consistency with the
Cronbach’s α of 0.90 using inner-city patients with hypertension (Shea, Misra, Ehrlich,
Field, & Francis, 1992).
The MMAS is an 8-item instrument with dichotomous answers that are designed
to avoid a bias of positive responses from patients when responding to health
professionals (Schoenthaler et al., 2009; Schoenthaler et al., 2012 ). Questions 1 through
7 have “yes” or “no” responses, while Question 8 has a 5-point, Likert response scale (De
las Cuevas & Peñate, 2015). The total scores on the MMAS-8 range from 0 to 8 to
demonstrate the continuous levels of adherence (De las Cuevas & Peñate, 2015; OliveiraFilho et al., 2012). A high score between 7 and 8 points represents high adherence, while
a score below 6 points corresponds to less adherence to medication. The scale is also
useful in better understanding behaviors related to medication use that may be
intentional, such as not taking medication due to side effects, or unintentional, such as
forgetfulness.
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Physician Communication Style
I assessed patient-provider communication with a measuring instrument that
originated from a study assessing the effect of physicians’ initial and follow-up
communication styles on beliefs and behaviors of patients with depression (see
Schoenthaler et al., 2009). This communication instrument uses concepts from the health
communication model and evaluates a patient’s perception of the quality of their
physicians’ communication style as well as the extent to which the physician encourages
patient participation in treatment process (Schoenthaler et al., 2012). The 13-item
communication scale, also used as a measuring instrument in the CAATCH trial, was
appropriate for this doctoral study because it focuses on how physicians monitor patients’
medication use, which is an important component in having a collaborative patientprovider relationship.
The first 11 questions are based on a Likert-type scale. Questions include: “To
what degree was your doctor: 1 = friendly during the visit?” and “To what extent did your
doctor: 2 = ask if you had questions and concerns?” The total scores for the survey range
from 1 to 4 with higher scores corresponding to better communication (Lewis et al.,
2012; Schoenthaler et al., 2012). Additionally, the communication scale has been used in
a study that evaluated the effects of patients’ perceptions of health providers’
communication on medication adherence in hypertensive African Americans
(Schoenthaler et al., 2009). These researchers found the scale valid and reliable with a
reported Cronbach’s alpha of .92.
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Medical Outcome Study – Social Support Survey (MOS-SS)
I measured social support using the Medical Outcome Study Social Support
Survey (MOS-SS), another measuring instrument used in the CAATCH trial. The survey
was developed for patients with chronic conditions, including hypertension, in the MOS
(Grant et al., 2015; Moser et al., 2012; Sherbourne & Steward, 1991). The survey is a 19item, self-administered questionnaire that measures multidimensional functional
characteristics of the availability of perceived social support (Grant et al., 2015. The four
domains of functional support covered within the questionnaire include
emotional/informational support, tangible or instrumental support, positive social
interaction, and affection (Grant et al., 2015; Schoenthaler et al., 2016). The survey uses a
5-point, Likert scale. Questions include: “How often is each of the following kind of
support available to you if you need it?” and “Someone you can count on to listen to you
when you need to talk.” The overall social support score is measured by obtaining the
average of the mean scores of the four domains or subscales (Schoenthaler et al., 2016).
The MOS-SS is scored using the formula 100 x (observed score-minimum) / (maximumminimum); this formula is used for getting total and subscale scores (Moser et al., 2012;
Sherbourne & Steward, 1991). Moreover, the MOS-SS has response options ranging
between 1 and 5; a higher score corresponds with greater social support (Grant et al.,
2015).
The MOS-SS survey is a widely used, short, simple, and easy-to-understand
measuring instrument that has been administered to cancer patients and chronically ill
patients of all ages. Additionally, the instrument has been found to be valid and reliable.
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For example, in the 2-year study of patients with chronic conditions conducted by
Sherbourne and Stewart (1991) to better understand the various functions of social
support, the MOS-SS was found to have a construct validity of 0.88. Internal-consistency
reliability was also tested, and Cronbach’s alpha showed tangible support of 0.92;
emotional support scale of 0.96, affection of 0.91, positive interaction of 0.94; and overall
support index of 0.97. In another study that examined and validated the psychometric
properties of a modified MOS-SS in two populations of women with breast cancer,
Moser et al. (2012) showed both internal reliability and construct validity to be good.
Research Questions and Hypotheses
Through this research study, I aimed to answer the following three questions by
evaluating their associated hypotheses:
Research Question 1: Are social support and patient-provider communication
associated with hypertensive African Americans self-reported medication
adherence?
H01: The null hypothesis states that there is no significant difference in
adherence to medication between individuals with and without social
support and patient-provider communication.
H11: The alternative hypothesis states that there is a significant difference
in adherence to medication between individuals with and without social
support and patient-provider communication.
Research Question 2: What is the association of social support and patientprovider communication by age among hypertensive African Americans?
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H02: The null hypothesis states that there is no significant difference in the
relationship between social support and patient-provider communication
and adherence by age among hypertensive African Americans.
H12: The alternative hypothesis states that there is a significant difference
in the relationship between social support and patient-provider
communication and adherence by age among hypertensive African
Americans.
Research Question 3: What is the association of social support and patientprovider communication among hypertensive African American men and women?
H03: The null hypothesis states that there is no significant difference in
adherence to medication between hypertensive African American men and
women with or without patient-provider communication and social
support.
H13: The alternative hypothesis states that there is a significant difference
in adherence to medication between hypertensive African American men
and women with or without patient-provider communication and social
support.
Data Analysis
Data were analyzed and interpreted using the Statistical Package for the Social
Sciences (SPSS) software, Version 25 (IBM Corp, 2012). Univariate analysis, which
includes the frequency and percentage distributions, was used to describe
sociodemographic characteristics of the study participants, physician communication
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style, and adherence variables. Through this analysis, I determined whether all data met
the appropriate assumptions. The mean and standard deviation were reported for ratio and
interval variables. Missing data were automatically excluded by SPSS when the logistic
regression model was created.
Furthermore, because the dependent variable was binary, a binomial logistic
regression analysis was conducted to address the three research questions since the
dependent variable in each of the different research questions which was adherence to
medication is a binary variable. A binomial logistic regression predicts the probability
that an observation falls into one of two categories of a dichotomous dependent variable
based on one or more independent variables that can be either continuous or categorical
(Statistics Solutions, 2017). In addition, a hierarchical form of the logistic regression was
used to control for confounders in all logistic regression models created. Hierarchical
logistic regression analysis is conducted when the dependent variable is dichotomous or
has two categories and is useful as a model-building technique in any regression model
by adding more predictors (Statistics Solutions, 2017). Furthermore, hierarchical
regression is a way to show if variables of interest explain a statistically significant
amount of variance in the dependent variable after accounting for all other variables.
Unadjusted and adjusted hierarchical logistic regression models were estimated
and compared to evaluate and control for the potential effect of confounders including
age, gender, income, education, marital status, employment, and health insurance that
have been shown to influence medication adherence. Two blocks in the regression model
were used for the unadjusted results. The first block included the control variables or
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covariates. The second block controlled the effects of these covariates while determining
the impact of the independent variables which are social support and patient-provided
communication on medication adherence. The Likelihood Ratio test was used to test
whether all predictor variables in a model are simultaneously zero, and the Wald test was
used to test whether particular predictor variables in a model are zero. Predictors that are
significantly associated (p < 0.05) with the dependent variable were included in the
model, and dropped from the model otherwise. Comparing the unadjusted and adjusted
hierarchical logistic regression helped to provide the best possible estimate of the impact
of the primary predictors while controlling for or reducing bias. The resulting model
helped me to estimate the adjusted odds ratio to explain the strength of the association
between the independent variables of patient-provider communication and social support,
and the dependent variable of medication adherence, while adjusting for potential
confounders.
I interpreted the results using a two-tailed test with a confidence interval of 95%.
To determine the statistical significance, the null hypotheses was rejected if p < 0.05.
Measures of central tendency and dispersion were used to identify skewness of the data,
outliers or leverage points. The fit of the models was evaluated using a modified version
of the Hosmer-Lemeshow test. The modified Hosmer-Lemeshow test treats the
multinomial model as if it were a set of independent ordinary logistic regressions models
of each outcome against a reference group and tests the fit for each independent model
separately (Statistics Solutions, 2017).
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Threats to Validity
Validity is necessary to ensure that what is intended on being measured within the
study is actually being measured. Internal and external validity can influence the study
results and findings. Internal validity refers to ability to make casual inferences about the
target population (Creswell, 2009). Conversely, external validity is the extent to which
the results can be generalized to a larger population (Frankfort-Nachmias & Nachmias,
2008). This doctoral study was limited by threats to internal and external validities. A
potential threat to internal validity for this study was the measuring instrumentations.
Effective changes in instrumentation can have an impact on the outcome scores
(Creswell, 2009; Datt, 2016). Therefore, the same measuring instruments used to collect
data in the original CAATCH trial were used for this study that relate to this study’s
research variables. The measuring instruments being used in this doctoral study not only
aligned with the theoretical framework, but have been previously established as reliable
and valid.
Another potential threat to internal validity was the attrition rate. The attrition rate
refers to the mortality or drop-out rate among participants, which can lead to incomplete
outcome data (Datt, 2016). According to Ogedegbe et al. (2014), the CAATCH trial had
an attrition rate of 30%; hence, the data for this study were weighted in order to be
representative of the population being examined. Moreover, the external validity of the
current study may be limited by the representativeness of the sample. The focus of the
study was on African Americans between the ages of 35–65 years. Obtaining a good
representativeness of the sample can be addressed through the specific inclusion and
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exclusion criteria, as well as using participants who have complete data on the measures
being examined. Participants for the study reflected the characteristics of the target
population based on such criteria and can potentially be representative of other
hypertensive African American patients.
Ethical Considerations
This doctoral study presented no risk to study participants. No physical
experimentation was performed. Participants were subject to questionnaires and surveys
only. Additionally, participants’ names and personal information were excluded from the
surveys. As previously stated, permission to use data for the study was obtained by a
written e-mailed letter to the original researchers. All data remained anonymous and
participants were identified by a generic code. Data were treated with extreme
confidentiality and stored on a secure and encrypted flash drive. Only myself and a
statistician had access to the secondary data. Official approval to collect data for this
doctoral study was granted from the Walden University Institutional Review Board office
(Approval # 07-18-18-0542557).
Summary
In this doctoral study, I used a quantitative cross-sectional design and collected
data from a secondary data set. The target population for the study focused on
hypertensive African American men and women between the ages of 21–65 years.
Participants were randomly selected using characteristic as specified in the sampling
frame. Moreover, survey instruments were used for data collection. The G*Power
software was also used to calculate the sample size, and SPSS software was used for data
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analysis. In Section 3, I will discuss the data collection of the secondary data set. In
Section 4, I will present the results and findings from the data analysis.
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Section 3: Presentation of the Results and Findings
Introduction
The purpose of this quantitative cross-sectional study was to examine the
association between social support and patient-provider communication related to
medication adherence for hypertensive African American men and women between the
ages of 21–65 years old in the United States. The independent variables in this study were
patient-provider communication and social support, while the dependent variable in this
study was adherence to prescribed medication among hypertensive African Americans.
The covariates in this study were age, gender, marital status, education, employment,
income, and insurance. I conducted descriptive statistical analysis and hierarchical
logistic regression analysis to address the objectives of the study and used SPSS to run
the different statistical analyses. Specifically, the following research questions and
hypotheses were tested in the quantitative analysis:
Research Question 1: Are social support and patient-provider communication
associated with hypertensive African Americans self-reported medication
adherence?
H01: There is no significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
H11: There is a significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
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Research Question 2: What is the association between social support and patientprovider communication by age among hypertensive African Americans?
H02: There is no significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
H12: There is a significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
Research Question 3: What is the association between social support and patientprovider communication among hypertensive African American men and women?
H03: There is no significant difference in the relationship between social
support and patient-provider communication and adherence between
hypertensive African American men and women.
H13: There is a significant difference in the relationship between social
support and patient-provider communication and adherence between
hypertensive African American men and women.
Data Collection
The target population in this study consisted of hypertensive African American
men and women between the ages of 21 and 65 years old. I used secondary data in this
study from the survey administered originally in the CAATCH clinical trial study. Data
from the CAATCH study were collected between 2004 and 2011. The CAATCH study is
considered the largest, practice-based, implementation trial of a multilevel, evidence-
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based intervention targeted towards blood pressure control in hypertensive African
Americans (Ogedegbe et al., 2014). In the CAATCH, the African American patients with
uncontrolled hypertension were chosen from 30 community health centers where they
received care and randomly assigned to the intervention condition or usual care condition
(Ogedegbe et al., 2009). Patients were recruited through letters from their primary care
clinician (Ogedegbe et al., 2014).
For this study, the minimum required number of sample participants was 248,
based on the results of a power analysis. Initially, I obtained a total of 1,059 samples but
removed 493 (48.5%) samples that did not meet the inclusion criteria of this study. Those
excluded from the final data set were not African American or did not fit within the
inclusion criteria for age (i.e., between the ages of 21 and 65 years old). Specifically,
among these 493 samples that were removed, 19 (1.88% of the total sample) were aged
less than 21 years old, 249 (23.5% of the total sample) were aged greater than 65 years
old, and 225 (21.2% of the total sample) were not African American. The final number of
samples of the study consisted of 566 (51.5% of the total sample) hypertensive African
American men and women between the ages of 21 and 65 years old. The final number of
566 participants was acceptable because it was more than the requirement of 248
participants deemed necessary by the power analysis.
Demographic Information
I considered the demographic data as covariates in this study. The demographic
information included age, gender, marital status, education, employment, income, and
insurance. Table 2 displays the demographic information of the sample population. The
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mean age of the 566 hypertensive African American men and women was 51.91 years old
(SD = 8.66). Concerning gender, more than half of the 566 samples of hypertensive
African Americans were females (n = 381, 67.3%). The majority of the sample were not
of Hispanic origin (n = 545, 96.3%). For marital status, the majority of the participants
were never married (n = 208, 36.7%), while 135 (23.9%) were married. For education
level, the top three highest degrees or levels of school completed were high school (n =
182, 32.2%), Grade 9 (n = 154, 27.2%), and some college (n = 120, 21.2%). For
employment status, only 193 (34.1%) out of the 566 participants were employed. For
insurance, more than half of the sample reported having Medicaid (n = 341, 60.2%). For
income, a majority of the 566 participants were in the low-income group (n = 491,
86.8%).
Table 2
Frequency and Percentage Summaries of Gender, Marital Status, Education,
Employment, Insurance, and Income
Frequency
Gender/sex
0 Male
1 Female
Missing
Are you of Hispanic origin?
0 Not Hispanic
1 Hispanic
Missing
Race
0 African American
Marital status
0 Never Married

Percent

184
381
1

32.5
67.3
0.2

545
10
11

96.3
1.8
1.9

566

100.0

208

36.7
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1 Married
2 Divorced
3 Separated
4 Widowed
Missing
Education: Highest degree or level of school completed
0 None
1 Grades 8
2 Grades 9
3 High School
4 Technical School
5 Some College
6 Associates
7 Bachelors
8 Graduate School, Masters or Above
Missing
Employment
0 No
1 Yes
Missing
Insurance: Do you have Private insurance such as Blue
Cross, Aetna, 1199 Fund, etc.?
0 No
1 Yes
Missing
Insurance: Medicare
0 No
1 Yes
Missing
Insurance: Medicaid
0 No
1 Yes
Missing
Insurance: HMO
0 No

Frequency
135
88
77
50
8

Percent
23.9
15.5
13.6
8.8
1.4

4
21
154
182
13
120
15
34
16
7

0.7
3.7
27.2
32.2
2.3
21.2
2.7
6.0
2.9
1.2

355
193
18

62.7
34.1
3.3

258
78
230

45.6
13.8
40.6

258
77
231

45.6
13.6
40.8

116
341
109

20.5
60.2
19.3

245

44.3
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1 Yes
Missing
Insurance: Military or Veteran's Administration
sponsored
0 No
1 Yes
Missing
Insurance: No insurance?
0 No
1 Yes
Missing
Income Level
0 Low income
1 High income
Missing

Frequency
100
215

Percent
17.7
38.0

300
3
263

53.0
0.5
46.5

276
41
249

48.8
7.2
44.0

491
58
17

86.8
10.3
3.0

Adherence to Prescribed Medication
As previously stated, the dependent variable was adherence to prescribed
medication among hypertensive African American. I measured adherence to prescribed
medication using the MMAS instrument. Adherence to prescribed medication was
measured at three time periods: at baseline (i.e., starting period of data collection), at
Time 3 (i.e., after 12 months), and at Time 5 (i.e., after 24 months follow-up). Tables 3
and 4 display the adherence to prescribed medication among hypertensive African
Americans. At baseline, the mean total score in the MMAS was 3.62 (SD = 1.46),
wherein less than half, or 219 (38.7%) of the 566 samples, of hypertensive African
Americans adhered to prescribed medication at the baseline period. At Time 3, the mean
total score in the MMAS was 3.19 (SD = 1.74), wherein less than half, or 147 (26%) out
of the 566 samples, of hypertensive African Americans adhered to prescribed medication.
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At Time 5, the mean total score in the MMAS was 3.85 (SD = 1.39), wherein less than
half, or 188 (33.2%) out of the 566 samples, of hypertensive African Americans adhered
to prescribed medication at the Time 5 period. As a comparison, the samples of
hypertensive African American samples had the highest frequency of adherence to
prescribed medication at baseline and had the least frequency of adherence to prescribed
medication at Time 3 or at period after 12 months.
Table 3
Frequency and Percentage Summaries of Adherence to Prescribed Medication Among
Hypertensive African Americans at Baseline, Time 3, and Time 5

Morisky medication adherence, at baseline
0 Nonadherent
1 Adherent
Missing
Morisky medication adherence, at Time 3 (12 months)
0 Nonadherent
1 Adherent
Missing
Morisky medication adherence, at Time 5 (24 months)
0 Nonadherent
1 Adherent
Missing

Frequency

Percent

339
219
8

59.9
38.7
1.4

286
147
133

50.5
26.0
23.5

215
188
163

38.0
33.2
28.8
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Table 4
Descriptive Statistics Summaries of Total Scores of Morisky Medication Among
Hypertensive African Americans at Baseline, Time 3, and Time 5

Morisky medication
adherence, at baseline
(total score)
Morisky medication
adherence, at Time 3 (total
score)
Morisky medication
adherence, at Time 5 (total
score)

N
Minimum Maximum
558
0
5

M
3.62

SD
1.46

433

0

5

3.19

1.74

403

0

5

3.85

1.39

Patient-Provider Communication
One of the independent variables was patient-provider communication. I
measured patient-provider communication using the Physician Communication Style
Survey. Table 5 presents the patient-provider communication scores among hypertensive
African Americans. The mean score for patient-provider communication of the 566
samples of hypertensive African Americans was 2.198 (SD = 0.75). The mean score was
at the average levels, which indicated that the hypertensive African American reported an
average quality of communication with their physicians.
Table 5
Descriptive Statistics Summaries of Total Scores of Patient-Provider Communication

Patient-Provider
communication

N

Minimum

Maximum

Mean

Std. Dev.

502

0

3

2.18

0.75

Social Support
Another independent variable was the social support that the hypertensive African
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Americans have received. I measured social support was measured using the MOS-SS.
The MOS-SS has five different measures, including the overall support index and the
four domain scores of emotional support, tangible support, affect, and positive
interaction. Social support was also measured at three time periods: at baseline, at Time
3, and at Time 5. Table 6 indicates the social support among hypertensive African
Americans.
For the overall support index, the hypertensive African American sample
participants had the highest overall support index at Time 5 (M = 3.90, SD = 0.92) and
had the lowest overall support index at baseline (M = 3.75, SD = 0.96). For the domain of
emotional support, the participants had the highest emotional support at Time 5 (M =
3.88, SD = 0.97) and had the lowest emotional support at baseline (M = 3.70, SD = 1.03).
For the domain of tangible support, the participants had the highest tangible support at
Time 5 (M = 3.84, SD = 1.13) and had the lowest tangible support at baseline (M = 3.65,
SD = 1.23). For the domain of affection, the participants had the highest affection at Time
5 (M = 4.07, SD = 1.09) and had the lowest affection at Time 3 (M = 4.00, SD = 1.12).
For the domain of positive interaction, the participants had the highest affection at Time 5
(M = 3.89, SD = 1.09) and had the lowest affection at baseline (M = 3.76, SD = 1.10).
This indicated that the participants had the highest social support at Time 5, which is the
ending period, and had the lowest social support at the baseline period.
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Table 6
Descriptive Statistics Summaries of Scores of Overall Support Index and Domain Scores
of Emotional Support, Tangible Support, Affection, and Positive Interaction Among
Hypertensive African Americans at Baseline, Time 3, and Time 5
Period
Baseline

Time 3

Time 5

Measure
Overall support index
Emotional support
Tangible support
Affection
Positive interaction
Overall support index
Emotional support
Tangible support
Affection
Positive interaction
Overall support index
Emotional support
Tangible support
Affection
Positive interaction

N
Min.
493
1
493
1
493
1
493
1
493
1
363
1
363
1
363
1
362
1
362
1
406
1.05
406
1
406
1
406
1
405
1

Max.
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

M
3.75
3.70
3.65
4.02
3.76
3.79
3.77
3.67
4.00
3.80
3.90
3.88
3.84
4.07
3.89

SD
0.96
1.03
1.23
1.12
1.10
0.93
0.98
1.17
1.12
1.12
0.92
0.97
1.13
1.09
1.09

Results
Hierarchical logistic regression analysis was conducted to address Research
Question 1 and examine the association of social support and patient-provider
communication towards medication adherence for both hypertensive African American
men and women between the ages of 21–65 years in the United States, while controlling
for the potential confounding effect of age, gender, marital status, education,
employment, income, and insurance. Hierarchical logistic regression analysis was also
conducted to determine whether there is a significant difference in the relationship
between social support and patient-provider communication and adherence by age and
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gender among hypertensive African Americans to address Research Questions 2 and 3,
respectively. The data used for the dependent variable of medication adherence and the
independent variable of social support were the data at Time 3, which is the period after
12 months follow-up from the baseline, were used in the hierarchical logistic regression
analysis in order to determine if there was a significant difference in adherence. Although
there were three time periods, analysis for period of Time 3 was selected to reduce the
possibility of significant redundancy of results. A level of significance of 0.05 was used
in the hierarchical logistic regression analysis. I concluded that there is a significant
predictive relationship and difference in adherence to medication if the p value of the
test is less than or equal to the level of significance value. Binomial logistic regression
analysis is conducted to address the three research questions since the dependent variable
in each of the different research questions which was adherence to medication is a binary
variable (Nonadherent versus Adherent). A binomial logistic regression predicts the
probability that an observation falls into one of two categories of a dichotomous
dependent variable based on one or more independent variables that can be either
continuous or categorical. In addition, a hierarchical form of the logistic regression was
used in order to controlling for the potential confounding effect of age, gender, marital
status, education, employment, income, and insurance in all logistic regression models
created.
Results of Hierarchical Logistic Regression Analysis for Research Question 1
Hierarchical logistic regression analysis was conducted to examine the association
of social support and patient-provider communication towards medication adherence. I
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performed this analysis while controlling for the potential confounding effect of age,
gender, marital status, education, employment, income, and insurance. The results of the
hierarchical logistic regression are shown in Table 8.
The results of the Hosmer-Lemeshow test showed that the model fit of
hierarchical logistic regression was insignificant (

(8) = 2.71, p = 0.95), which

indicated that the regression model for Model 2—which is the regression model in
determining the predictive relationship of social support and patient-provider
communication with medication adherence controlling for the potential confounding
effect of age, gender, marital status, education, employment, income, and insurance—had
an acceptable model fit. With the Hosmer-Lemeshow test, if p > 0.05, then the model has
an acceptable fit. This means that the predictive relationship of social support and patientprovider communication with medication adherence after controlling for the potential
confounding effect of age, gender, marital status, education, employment, income, and
insurance was insignificant. The Cox and Snell R2, or measure of effect size, of Model 2
of the hierarchical logistic regression model was 0.15, which indicated a low effect size,
meaning that both the independent variables of social support and patient-provider
communication explained a variance of only 15% to predict medication adherence after
controlling for age, gender, marital status, education, employment, income, and
insurance.
On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic
regression model was 0.20, which also indicated a low effect size, meaning that both the
independent variables of social support and patient-provider communication explained a
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variance of only 20% to predict medication adherence after controlling for age, gender,
marital status, education, employment, income, and insurance. Table 7 illustrates the
results of the classification table, which indicated that there was 82.4% of hypertensive
African American samples that were nonadherent to the prescribed medication that were
correctly predicted and there were 45.1% of hypertensive African American samples that
were adherent to the prescribed medication. The overall accuracy of the prediction of the
medication adherence was 67.1%.
My investigation of the individual predictive relationship in the hierarchical
logistic regression model in Table 8 showed that only the patient-provider
communication (Wald (1) = 4.43, p = 0.04) was significantly associated or have a
significant predictive relationship with medication adherence after controlling for the
potential confounding effect of age, gender, marital status, education, employment,
income, and insurance. There was a significant predictive relationship because the p
value was less than the level of significance value of 0.05. The examination of the
coefficient of the odd ratio statistic of Exp(β) showed that the odds ratio of patientprovider communication was 1.72, which implied that a one-unit increase in patientprovider communication score increased the odds of the hypertensive African Americans
to adhere to prescribed medication—versus not adhering to prescribed medication—by
0.72 or 72%.
In contrast, the overall support index (Wald (1) = 1.05, p = 0.31) was not
significantly associated or have significant predictive relationships with medication
adherence after controlling for the potential confounding effect of age, gender, marital
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status, education, employment, income, and insurance. With these results of the
hierarchical logistic regression analysis, the first null hypothesis—which states that there
is no significant difference in adherence to medication between individuals with and
without social support and patient-provider communication—was rejected. The
alternative hypothesis—which states that there is a significant difference in adherence to
medication between individuals with and without social support and patient-provider
communication—was supported. A significant association was observed only between
patient-provider communication and medication adherence.
Table 7
Classification Table of Hierarchical Logistic Regression Model for Adherence to
Prescribed Medication Among Hypertensive African Americans
Observed

Morisky medication
adherence, at Time 3
(dichotomized)
Overall Percentage

Predicted
Morisky medication
adherence, at Time 3
(dichotomized)
Nonadherent
Adherent
Nonadherent
84
18
Adherent

39

32

Percentage
Correct

82.4
45.1
67.1
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Table 8
Hierarchical Logistic Regression Results of Association of Social Support and PatientProvider Communication with Adherence to Prescribed Medication Among Hypertensive
African Americans Controlling for Age, Gender, Marital Status, Education, Employment,
Income, and Insurance
Block
1

2

Variables
Sex (Female)
Age
Marital status (Never Married):
Reference Category
Marital status (Married)
Marital status (Divorced)
Marital status (Separated)
Marital status (Widowed)
Education (None): Reference
Category
Education (Grades 8)
Education (Grades 9)
Education (High School)
Education (Technical School)
Education (Some College)
Education (Associates)
Education (Bachelors)
Education (Graduate School,
Masters or above)
Employment (Yes)
Insurance: Private Insurance
(Yes)
Insurance: Medicare (Yes)
Insurance: Medicaid (Yes)
Insurance: HMO (Yes)
Insurance: No insurance? (Yes)
Income
Constant
Sex (Female)
Age
Marital status (Never Married):
Reference Category

B

Wald

df

p

0.40
0.02

3.26
6.12

1
1

0.07
0.01

0.49
1.06

0.67
0.72
0.76
0.78

1.85
0.01
0.01
0.69
0.52

4
1
1
1
1

0.76
0.91
0.94
0.41
0.47

0.93
0.94
0.53
0.57

-20.27
-0.29
-0.65
-0.18
-0.18
0.26
-1.00

28167.94
1.09
0.96
0.95
1.35
0.96
1.66

3.92
0.00
0.07
0.45
0.03
0.02
0.07
0.36

8
1
1
1
1
1
1
1

0.86
1.00
0.79
0.50
0.85
0.90
0.79
0.55

0.00
0.75
0.52
0.84
0.84
1.30
0.37

0.48
0.18

1.08
0.48

0.19
0.14

1
1

0.66
0.71

1.61
1.20

0.59
0.19
0.53
0.34
-0.63
-0.06
-3.37

0.65
0.56
0.52
0.46
0.81
0.20
2.54

0.83
0.12
1.05
0.57
0.60
0.10
1.76

1
1
1
1
1
1
1

0.36
0.73
0.31
0.45
0.44
0.75
0.18

1.80
1.21
1.71
1.41
0.54
0.94
0.03

-0.64
0.06

0.41
0.02

2.49
5.26

1
1

0.12
0.02

0.53
1.06

-0.72
0.06

-0.07
-0.06
-0.63
-0.56

S.E.

2.01

Exp (B)

4 0.73
Table continues
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Block

Variables
B
S.E.
Wald df
p
Exp (B)
Marital status (Married)
-0.14
0.70
0.04 1 0.84
0.87
Marital status (Divorced)
-0.20
0.75
0.07 1 0.79
0.82
Marital status (Separated)
-0.80
0.80
1.01 1 0.32
0.45
Marital status (Widowed)
-0.59
0.81
0.53 1 0.47
0.56
Education (None): Reference
Category
5.04 8 0.75
Education (Grades 8)
-21.12 28397.57
0.00 1 1.00
0.00
Education (Grades 9)
-0.83
1.16
0.51 1 0.48
0.44
Education (High School)
-1.10
1.03
1.15 1 0.29
0.33
Education (Technical School)
-0.70
1.02
0.47 1 0.49
0.50
Education (Some College)
-0.55
1.43
0.15 1 0.70
0.58
Education (Associates)
-0.14
1.02
0.02 1 0.89
0.87
Education (Bachelors)
-1.74
1.70
1.06 1 0.30
0.18
Education (Graduate School,
Masters or above)
0.19
1.13
0.03 1 0.87
1.21
Employment (Yes)
0.21
0.49
0.19 1 0.66
1.24
Insurance: Private Insurance
(Yes)
0.75
0.66
1.29 1 0.26
2.11
Insurance: Medicare (Yes)
0.25
0.58
0.18 1 0.67
1.28
Insurance: Medicaid (Yes)
0.56
0.54
1.08 1 0.30
1.76
Insurance: HMO (Yes)
0.18
0.49
0.13 1 0.72
1.19
Insurance: No insurance? Yes)
-0.81
0.85
0.93 1 0.34
0.44
Income
-0.05
0.21
0.05 1 0.82
0.96
Patient-Provider communication
0.54
0.26
4.43 1 0.04
1.72
Overall support index at Time 3
0.21
0.20
1.05 1 0.31
1.23
Constant
-4.62
2.63
3.08 1 0.08
0.01
Note. Hosmer-Lemeshow X2(8) = 2.71, p = 0.95, Cox & Snell R2 = 0.15, Nagelkerke R2 = 0.20,
N = 173

Results of Hierarchical Logistic Regression Analysis for Research Question 2
Hierarchical logistic regression analysis was also conducted to examine the
association of social support and patient-provider communication with medication
adherence by age among hypertensive African Americans controlling for the potential
confounding effect of gender, marital status, education, employment, income, and
insurance. The hierarchical logistic regression analysis was conducted to determine
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whether there is a significant difference in the relationship between social support and
patient-provider communication and adherence by age among hypertensive African
Americans. I investigated the significance of the interaction effects of social support and
age, as well as of patient-provider communication and age, on medication adherence. The
results of the hierarchical logistic regression with age are shown in Table 10.
The results of the Hosmer-Lemeshow test showed that the model fit of
hierarchical logistic regression was insignificant (χ2 (8) = 6.43, p = 0.60), which indicated
that the regression model for Model 2—which is the regression model in determining the
association of social support and patient-provider communication with medication
adherence by age controlling for the potential confounding effect of gender, marital
status, education, employment, income, and insurance—had an acceptable model fit. This
means that the association of social support and patient-provider communication with
medication adherence by age among hypertensive African Americans after controlling for
the potential confounding effect of gender, marital status, education, employment,
income, and insurance was insignificant. The Cox and Snell R2, or measure of effect size,
of Model 2 of the hierarchical logistic regression model was 0.16, which indicated a low
effect size, meaning that individual effects of the independent variables of social support,
patient-provider communication, and age; and the interaction effects of overall social
support and age; and patient-provider communication and age explained a variance of
only 16% to predict medication adherence after controlling for gender, marital status,
education, employment, income, and insurance.
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On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic
regression model was 0.22, which also indicated a low effect size, meaning that the
individual effects of the independent variables of social support, patient-provider
communication, and age; and the interaction effects of overall social support and age; and
patient-provider communication and age explained a variance of only 22% to predict
medication adherence after controlling for gender, marital status, education, employment,
income, and insurance. Table 9 showed the results of the classification table, which
indicated that there was 76.5% of hypertensive African American samples that were
nonadherent to the prescribed medication that were correctly predicted and there were
45.1% of hypertensive African American samples that were adherent to the prescribed
medication when considering the interaction effect of age. The overall accuracy of the
prediction of the medication adherence was 63.6% when considering the interaction
effect of age.
My investigation of the individual predictive relationship in the hierarchical
logistic regression model in Table 11 showed the individual effects of overall support
index (Wald(1) = 2.27, p = 0.13), patient-provider communication (Wald(1) = 0.00, p =
0.95), and age (Wald(1) = 1.88, p = 0.17) were not significantly associated or do not have
a significant predictive relationship with medication adherence after controlling for the
potential confounding effect of gender, marital status, education, employment, income,
and insurance. The results of the hierarchical logistic regression showed that medication
adherence was not significantly different by the individual differences of age among
hypertensive African Americans. Also, the interaction effects of overall social support
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and age (Wald(1) = 1.87, p = 0.17) and patient-provider communication and age (Wald(1)
= 0.14, p = 0.71) on medication adherence after controlling for the potential confounding
effect of gender, marital status, education, employment, income, and insurance were
insignificant. This means that there is no significant difference in the relationship
between social support and patient-provider communication and medication adherence by
age among hypertensive African Americans. The results were insignificant because the p
values were all greater than the level of significance value. With these results of the
hierarchical logistic regression analysis, the second null hypothesis—which states that
there is no significant difference in the relationship between social support and patientprovider communication and adherence by age among hypertensive African Americans—
was not rejected.
Table 9
Classification Table of Hierarchical Logistic Regression Model for Adherence to
Prescribed Medication Among Hypertensive African Americans Considering Interaction
Effect of Age
Observed

Morisky medication
adherence, at Time 3
(dichotomized)
Overall Percentage

Predicted
Morisky medication
adherence, at Time 3
(dichotomized)
Nonadherent
Adherent
Nonadherent
78
24
Adherent

39

32

Percentage
Correct

76.5
45.1
63.6
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Table 10
Hierarchical Logistic Regression Results of Individual Association and Interaction
Effects of Social Support, Patient-Provider Communication, and Age with Adherence to
Prescribed Medication Among Hypertensive African Americans Controlling for Gender,
Marital Status, Education, Employment, Income, and Insurance
Block
1

2

Variables
Sex (Female)
Marital status (Never Married):
Reference Category
Marital status (Married)
Marital status (Divorced)
Marital status (Separated)
Marital status (Widowed)
Education (None): Reference
Category
Education (Grades 8)
Education (Grades 9)
Education (High School)
Education (Technical School)
Education (Some College)
Education (Associates)
Education (Bachelors)
Education (Graduate School,
Masters or above)
Employment (Yes)
Insurance: Private Insurance
(Yes)
Insurance: Medicare (Yes)
Insurance: Medicaid (Yes)
Insurance: HMO (Yes)
Insurance: No insurance? (Yes)
Income
Constant
Sex (Female)
Marital status (Never Married):
Reference Category
Marital status (Married)
Marital status (Divorced)
Marital status (Separated)

-0.61

0.39

2.55

D
f
1

-0.30
-0.26
-0.59
-0.67

0.65
0.70
0.75
0.77

1.18
0.22
0.13
0.63
0.76

4
1
1
1
1

0.88
0.64
0.72
0.43
0.38

0.74
0.78
0.55
0.51

-21.35
-0.28
-0.98
-0.58
-0.64
-0.23
-1.28

28280.87
1.08
0.94
0.92
1.30
0.92
1.61

3.65
0.00
0.07
1.09
0.39
0.24
0.06
0.63

8
1
1
1
1
1
1
1

0.89
1.00
0.79
0.30
0.53
0.62
0.80
0.43

0.00
0.75
0.38
0.56
0.53
0.79
0.28

0.03
0.19

1.05
0.46

0.00
0.17

1
1

0.98
0.68

1.03
1.21

0.58
-0.10
0.55
0.33
-0.68
-0.07
0.47
-0.65

0.63
0.54
0.51
0.45
0.80
0.19
1.95
0.41

0.84
0.03
1.18
0.55
0.73
0.13
0.06
2.47

1
1
1
1
1
1
1
1

0.36
0.86
0.28
0.46
0.39
0.72
0.81
0.12

1.78
0.91
1.74
1.39
0.51
0.93
1.60
0.52

0.70
0.75
0.79

1.91
0.05
0.07
1.07

4
1
1
1

B

-0.15
-0.20
-0.82

S.E.

Wald

p

Exp (B)

0.11

0.54

0.75
0.83
0.86
0.79
0.82
0.30
0.44
Table continues
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Block

Variables

B

S.E.

Wald

D
f
1

p

Exp (B)

Marital status (Widowed)
-0.51
0.81
0.39
0.53
0.60
Education (None): Reference
Category
5.12 8 0.75
Education (Grades 8)
-21.59 28196.26
0.00 1 1.00
0.00
Education (Grades 9)
-1.04
1.20
0.75 1 0.39
0.36
Education (High School)
-1.31
1.07
1.49 1 0.22
0.27
Education (Technical School)
-0.89
1.06
0.70 1 0.40
0.41
Education (Some College)
-0.80
1.46
0.30 1 0.58
0.45
Education (Associates)
-0.37
1.06
0.12 1 0.73
0.69
Education (Bachelors)
-1.96
1.70
1.33 1 0.25
0.14
Education (Graduate School,
Masters or above)
-0.03
1.16
0.00 1 0.98
0.97
Employment (Yes)
0.24
0.49
0.23 1 0.63
1.27
Insurance: Private Insurance
(Yes)
0.86
0.67
1.68 1 0.20
2.37
Insurance: Medicare (Yes)
0.39
0.59
0.44 1 0.51
1.48
Insurance: Medicaid (Yes)
0.71
0.56
1.61 1 0.21
2.04
Insurance: HMO (Yes)
0.21
0.50
0.18 1 0.68
1.23
Insurance: No insurance? (Yes)
-0.73
0.87
0.70 1 0.40
0.48
Income
-0.05
0.21
0.05 1 0.82
0.95
Patient-Provider communication
-0.12
1.83
0.00 1 0.95
0.89
Overall support index at Time 3
1.92
1.27
2.27 1 0.13
6.80
Age
0.15
0.11
1.88 1 0.17
1.16
Patient-Provider communication *
Age Category
0.01
0.03
0.14 1 0.71
1.01
Overall support index at Time 3 *
Age Category
-0.03
0.02
1.87 1 0.17
0.97
Constant
-9.98
6.47
2.38 1 0.12
0.00
Note. Hosmer-Lemeshow X2(8) = 6.43, p = 0.60, Cox & Snell R2 = 0.16, Nagelkerke R2 = 0.22,
N = 173

Results of Hierarchical Logistic Regression Analysis for Research Question 3
Hierarchical logistic regression analysis was also conducted to examine the
association of social support and patient-provider communication with medication
adherence by gender among hypertensive African Americans controlling for the potential
confounding effect of age, marital status, education, employment, income, and insurance.
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The hierarchical logistic regression analysis was conducted to determine whether there is
a significant difference in the relationship between social support and patient-provider
communication and adherence by gender among hypertensive African Americans. I
investigated the significance of the interaction effects of social support and gender; and
patient-provider communication and gender on medication adherence. The results of the
hierarchical logistic regression with gender are shown in Table 12.
The results of the Hosmer-Lemeshow test showed that the model fit of
hierarchical logistic regression was insignificant (χ2 (8) = 8.31, p = 0.40), which indicated
that the regression model for Model 2—which is the regression model in determining the
association of social support and patient-provider communication with medication
adherence by gender controlling for the potential confounding effect of age, marital
status, education, employment, income, and insurance—had an acceptable model fit. This
means that the association of social support and patient-provider communication with
medication adherence by gender among hypertensive African Americans after controlling
for the potential confounding effect of age, marital status, education, employment,
income, and insurance was insignificant. The Cox and Snell R2, or measure of effect size,
of Model 2 of the hierarchical logistic regression model was 0.15, which indicated a low
effect size, meaning that individual effects of the independent variables of social support,
patient-provider communication, and gender; and the interaction effects of overall social
support and gender; and patient-provider communication and gender explained a variance
of only 15% to predict medication adherence after controlling for age, marital status,
education, employment, income, and insurance.
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On the other hand, the Nagelkerke R2 of Model 2 of the hierarchical logistic
regression model was 0.20, which also indicated a low effect size, meaning that the
individual effects of the independent variables of social support, patient-provider
communication, and gender; and the interaction effects of overall social support and
gender; and patient-provider communication and gender explained a variance of only
20% to predict medication adherence after controlling for age, marital status, education,
employment, income, and insurance. Table 11 showed the results of the classification
table, which indicated that there was 81.4% of hypertensive African American samples
that were nonadherent to the prescribed medication that were correctly predicted and
there were 46.5% of hypertensive African American samples that were adherent to the
prescribed medication when considering the interaction effect of gender. The overall
accuracy of the prediction of the medication adherence was 67.1% when considering the
interaction effect of gender.
My investigation of the individual predictive relationship in the hierarchical
logistic regression model in Table 12 showed the individual effects of overall support
index (Wald(1) = 0.89, p = 0.35), patient-provider communication (Wald(1) = 0.75, p =
0.39), and gender (Wald(1) = 0.30, p = 0.58) were not significantly associated or do not
have a significant predictive relationship with medication adherence after controlling for
the potential confounding effect of age, marital status, education, employment, income,
and insurance. The results of the hierarchical logistic regression showed that medication
adherence was not significantly different by the individual differences of gender among
hypertensive African Americans. Also, the interaction effects of overall social support
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and gender (Wald (1) = 0.23, p = 0.63) and patient-provider communication and gender
(Wald(1) = 0.10, p = 0.75) on medication adherence after controlling for the potential
confounding effect of age, marital status, education, employment, income, and insurance
were insignificant. This means that there is no significant difference in the relationship
between social support and patient-provider communication and medication adherence by
gender among hypertensive African Americans. The results were insignificant because
the p values were all greater than the level of significance value. With these results of the
hierarchical logistic regression analysis, the third null hypothesis—which states that there
is no significant difference in the relationship between social support and patient-provider
communication and adherence between hypertensive African American men and
women—was not rejected.
Table 11
Classification Table of Hierarchical Logistic Regression Model for Adherence to
Prescribed Medication Among Hypertensive African Americans Considering Interaction
Effect of Gender
Observed

Morisky medication
adherence, at Time 3
(dichotomized)
Overall Percentage

Predicted
Morisky medication
adherence, at Time 3
(dichotomized)
Nonadherent
Adherent
Nonadherent
83
19
Adherent

38

33

Percentage
Correct

81.4
46.5
67.1
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Table 12
Hierarchical Logistic Regression Results of Individual Association and Interaction
Effects of Social Support, Patient-Provider Communication, and Gender with Adherence
to Prescribed Medication Among Hypertensive African Americans Controlling for Age,
Marital Status, Education, Employment, Income, and Insurance
Block
1

Variables
Age
Marital status (Never Married):
Reference Category
Marital status (Married)
Marital status (Divorced)
Marital status (Separated)
Marital status (Widowed)
Education (None): Reference Category
Education (Grades 8)

2

Education (Grades 9)
Education (High School)
Education (Technical School)
Education (Some College)
Education (Associates)
Education (Bachelors)
Education (Graduate School, Masters or
above)
Employment (Yes)
Insurance: Private Insurance (Yes)
Insurance: Medicare (Yes)
Insurance: Medicaid (Yes)
Insurance: HMO (Yes)
Insurance: No insurance? (Yes)
Income
Constant
Age
Marital status (Never Married):
Reference Category
Marital status (Married)
Marital status (Divorced)

B
0.05

S.E.
0.02

Wal d
p
d
f
5.42 1 0.02

Exp
(B)
1.06

1.73
0.09
0.19
0.94
0.75
3.22

4
1
1
1
1
8

0.79
0.76
0.67
0.33
0.39
0.92

0.82
0.74
0.49
0.52

-0.20
-0.30
-0.72
-0.66

0.65
0.70
0.74
0.76

20.4
1
-0.25
-0.55
-0.02
0.02
0.25
-0.74

27605.
61
1.10
0.97
0.95
1.33
0.96
1.64

0.00
0.05
0.33
0.00
0.00
0.07
0.21

1
1
1
1
1
1
1

1.00
0.82
0.57
0.98
0.99
0.79
0.65

0.00
0.78
0.58
0.98
1.02
1.29
0.48

0.45
0.24
0.52
0.26
0.59
0.27
-0.70
-0.04
-3.27
0.06

1.09
0.47
0.63
0.55
0.51
0.45
0.81
0.20
2.51
0.02

0.17
0.26
0.68
0.22
1.34
0.36
0.75
0.04
1.70
5.20

1
1
1
1
1
1
1
1
1
1

0.68
0.61
0.41
0.64
0.25
0.55
0.39
0.85
0.19
0.02

1.57
1.27
1.68
1.29
1.81
1.31
0.50
0.96
0.04
1.06

0.70
0.75

1.94 4 0.75
0.05 1 0.82
0.85
0.07 1 0.79
0.82
Table continues

-0.16
-0.20
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Block

Variables

B

Marital status (Separated)
Marital status (Widowed)
Education (None): Reference Category
Education (Grades 8)

S.E.

-0.79
-0.62

0.80
0.81

21.0
1
-0.80
-1.05
-0.63
-0.47
-0.02
-1.61

28389.
48
1.17
1.06
1.04
1.44
1.05
1.71

Wal
d
0.98
0.59
5.13

d
p
f
1 0.32
1 0.44
8 0.74

0.00
0.47
0.98
0.37
0.11
0.00
0.88

1
1
1
1
1
1
1

1.00
0.50
0.32
0.54
0.74
0.98
0.35

Exp
(B)
0.45
0.54

0.00
0.45
0.35
0.53
0.62
0.98
0.20

Education (Grades 9)
Education (High School)
Education (Technical School)
Education (Some College)
Education (Associates)
Education (Bachelors)
Education (Graduate School, Masters or
above)
0.28
1.15 0.06 1 0.81
1.32
Employment (Yes)
0.21
0.49 0.19 1 0.66
1.24
Insurance: Private Insurance (Yes)
0.73
0.67 1.20 1 0.27
2.07
Insurance: Medicare (Yes)
0.20
0.59 0.12 1 0.73
1.23
Insurance: Medicaid (Yes)
0.55
0.55 1.03 1 0.31
1.74
Insurance: HMO (Yes)
0.15
0.49 0.09 1 0.76
1.16
Insurance: No insurance? (Yes)
-0.82
0.85 0.94 1 0.33
0.44
Income
-0.05
0.21 0.05 1 0.82
0.96
Patient-Provider communication
0.41
0.48 0.75 1 0.39
1.51
Overall support index at Time 3
0.37
0.39 0.89 1 0.35
1.44
Gender
-1.05
1.91 0.30 1 0.58
0.35
Patient-Provider communication *
Gender Category
0.18
0.56 0.10 1 0.75
1.20
Overall support index at Time 3 *
Gender Category
-0.22
0.45 0.23 1 0.63
0.80
Constant
-4.49
2.73 2.71 1 0.10
0.01
2
2
2
Note. Hosmer-Lemeshow X (8) = 8.31, p = 0.40, Cox & Snell R = 0.15, Nagelkerke R = 0.20,
N = 173

Summary
The purpose of this quantitative cross-sectional study was to examine the
association of social support and patient-provider communication towards medication
adherence for both hypertensive African American men and women between the ages of
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21–65 years in the United States. Descriptive statistics analysis and hierarchical logistic
regression analysis were conducted to test the research questions and hypotheses posed in
this study. The results of the hierarchical logistic regression analysis for Research
Question 1 showed that the patient-provider communication was significantly associated
or have a significant predictive relationship with medication adherence of hypertensive
African Americans after controlling for the potential confounding effect of age, gender,
marital status, education, employment, income, and insurance. Specifically, a higher
quality of patient-provider communication score would results to a higher odds or
probability of the hypertensive African Americans to adhere to prescribed medication
versus not adhering to prescribed medication. The results of the hierarchical logistic
regression analysis for Research Question 2 showed that there is no significant difference
in the relationship between social support and patient-provider communication and
adherence by age among hypertensive African Americans after controlling for the
potential confounding effect of gender, marital status, education, employment, income,
and insurance. The results of the hierarchical logistic regression analysis for Research
Question 3 showed that there is no significant difference in the relationship between
social support and patient-provider communication and adherence between hypertensive
African American men and women after controlling for the potential confounding effect
of age, marital status, education, employment, income, and insurance. In Section 4, I will
review the findings from the study, explain how they relate to the literature on this topic,
suggest implications for action, and provide recommendations for future research.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
Previous researchers have demonstrated the importance of medication adherence
of hypertensive patients for health improvement (Hill et al., 2011; Zullig et al., 2013).
The literature on the relationship of social support and patient-provider communication
and medication adherence among African Americans with hypertension, however, is still
lacking (Cornwell & Waite, 2012; Lewis et al., 2012). Therefore, the purpose of this
quantitative cross-sectional study was to investigate the association between social
support and patient-provider communication towards medication adherence for both
hypertensive African American men and women between the ages of 21 and 65 years in
the United States. In this study, I used social support and patient-provider communication
as the independent variables, while adherence to high blood pressure was the dependent
variable.
I used descriptive and hierarchal logistic regression model analyses to analyze
data from a total of 566 hypertensive African Americans. The first independent variable
was social support, which I defined as support perceived or received from family, friends,
health providers, faith and community organizations, and social networking groups or
programs that specifically help hypertensive individuals. The second independent
variable was patient-provider communication, which was defined as the patients’
perception of the provider and clarity of advice given to them. The dependent variable
was adherence to high blood pressure medication, which I defined as how well and
consistently a patient follows recommended treatment and the plan developed by his or
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her healthcare provider. The control variables were gender, age, income, education,
employment, insurance status, and place of residence. The length of time in treatment,
number of medications, and the severity of hypertension were also used as control
variables. The following research questions and hypotheses were used to guide the study:
Research Question 1: Are social support and patient-provider communication
associated with hypertensive African Americans self-reported medication
adherence?
H01: There is no significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
H11: There is a significant difference in adherence to medication between
individuals with and without social support and patient-provider
communication.
Research Question 2: What is the association between social support and patientprovider communication by age among hypertensive African Americans?
H02: There is no significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
H12: There is a significant difference in the relationship between social
support and patient-provider communication and adherence by age among
hypertensive African Americans.
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Research Question 3: What is the association between social support and patientprovider communication among hypertensive African American men and women?
H03: There is no significant difference in adherence to medication between
hypertensive African American men and women with or without patientprovider communication and social support.
H13: There is a significant difference in adherence to medication between
hypertensive African American men and women with or without patientprovider communication and social support.
The results of the analyses showed that among the three research questions, only
Research Question 1 indicated significant results. In particular, I found that patientprovider communication is a positive and significant predictor of medication adherence
of African Americans with hypertension. Social support, however, was not found to
significantly predict medication adherence. There was also no significant difference in
medication adherence based on age and gender. The results of this study revealed the
explicit relationships between social support, patient-provider communication, and
medication adherence in the context of African Americans with hypertension in the
United States.
It is especially important for researchers to understand the dynamics of patients
and providers and the former’s commitment to improve their health. The results of this
study provide additional context regarding factors that influence medication adherence
and overall healthcare experiences of African Americans with hypertension. In this
section, I will discuss the results of this study in light of the existing literature on African
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American with hypertension and their health-seeking behaviors as well as the influence
of social support, patient-provider communication, and other factors on medication
adherence.
Interpretation of Findings
In this section, I will interpret the results based on the existing related studies on
the role of support and patient-provider communication on medication adherence of
African Americans with hypertension. Hypertension is a chronic disease that greatly
affects the quality of life of individuals (Bokhour et al., 2016). Scholars have reported
that 45% of African American men and 46% of African American women have
hypertension, in comparison to 34% of European American men and 31% of European
American women (CDC, 2016; Pettey et al., 2016).
To answer the first research question, I focused on the relationship of social
support and patient-provider communication and their association with African American
self-reports of medication adherence. To answer the second research question, I
determined the association between social support and patient-provider communication
among African Americans with hypertension based on their age. To answer the third and
last research question, I tackled the relationship between medication adherence and social
support and patient-provider communication among hypertensive African American men
and women.
Social Support, Patient-Provider Communication, and Medication Adherence
Drawing from previous literature on the influence of both social support and
patient-provider communication (Levinson et al., 2010; Schoenthaler et al., 2009), I
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hypothesized that there would be a significant difference in adherence to medication
between individuals with and without social support and patient-provider communication.
The results of the hierarchal logistic regression analysis for Research Question 1 showed
that only patient-provider communication had a significant predictive relationship with
medication adherence. Social support was not found to be a significant predictor of
medication adherence. The positive finding on patient-provider communication as a
predictive variable of medication adherence lends further support to the conclusions of
Levinson et al. (2010) and Schoenthaler et al. (2009), who demonstrated that the
multidimensional role of patient-provider communication has a large impact on patients’
willingness to adhere to medication. The open communication between the patient and
provider allows the former to express their thoughts and feelings about their health,
treatment, and lifestyle choices (Braverman & Dedier, 2009). This increases the trust
between the patient and the provider and was found to be an effective means to
encourage patients with chronic diseases to be more responsible with regards to their
health (Martin et al., 2011).
This significant predictive role of patient-provider communication on medication
adherence among African Americans with hypertension provides further evidence on the
lived experiences of hypertensive African Americans. In another study, Martin et al.
(2011) concluded that lower levels of trust in health providers are also associated with
lower patient satisfaction and treatment adherence among racial minority populations,
including African Americans. This may be the reason why African Americans are less
likely to seek or receive needed health services, procedures, or routine treatments for
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hypertension in comparison to European Americans (Martin et al., 2011). The poor
quality of relationships between patients and provider is a barrier in improving healthcare
among ethnic minority groups. Based on the results of this study, the same could be said
concerning the situation of African Americans with hypertension. The distrust towards
providers has become a barrier that prevents African Americans from demonstrating
positive health-seeking behaviors (Abel & Efird, 2013).
On the other hand, the nonsignificant result of the relationship between social
support and medication adherence is incongruent to the findings of Nurullah (2012), who
showed that social support is vital in promoting better health outcomes and improving
chronic diseases, such as hypertension. According to the TRA, attitudes can be based on
multiple factors, including past experiences, social support, health education and literacy,
or the environment (Glanz et al., 2015). TRA also states that individual motivational
factors influence the likelihood of performing a specific behavior (Hackman &
Knowlden, 2014). In this case, I hypothesized that social support could be a significant
predictor variable of medication adherence. As such, the nonsignificant findings could be
cleared by looking into the social support experiences of African Americans with
hypertension or chronic diseases. Research on this topic is scarce; however, lack of social
support is considered a large barrier on medication adherence among African Americans
with chronic diseases (Rimando, 2013). It is possible that the types of social support used
in the present study were not comprehensive enough in capturing the experiences of
African Americans with hypertension. This could have also been a result of the
methodology used in this study. In any case, the disparity between the nonsignificant
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findings of this study on the predictor role of social support on medication adherence in
the context of African Americans with hypertension must be investigated further.
Medication Adherence Based on Age and Gender
To answer the second research question, I explored the association between social
support and patient-provider communication by age among hypertensive African
Americans, while in the third research question, I examined the role of gender on the
medication adherence behaviors of African Americans with or without patient-provider
communication and social support. I hypothesized (a) that there would be a significant
difference between old and young African Americans with hypertension in terms of
social support and patient-provider communication and (b) that there would be greater
adherence to treatment for African American women compared to men with higher
patient-provider communication and social support. These two research questions
focused on the presence of disparity, if any, by age and gender, respectively.
The results were nonsignificant for both research questions. Rates of uncontrolled
hypertension were found to be higher for African American older adults (Cornwell &
Waite, 2012). The results of Research Question 2—that medication adherence is not
significantly different between old and young African American—proved that in terms of
social support and patient-provider communication, the experiences of both old and
young African Americans are similar. In fact, this result substantiated previous scholars’
conclusions that age does not predict or influence medication adherence for hypertension
patients. For instance, Nair et al. (2011) posited that difference in age did not appear to be
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a reliable measure of influence of medication adherence among young and old African
Americans with hypertension.
Lewis (2012) further demonstrated that several studies did not show a significant
relationship between social support and medication adherence. This may be related to
attitudes towards medication adherence. Patients’ beliefs and attitudes towards
medication have been shown to be important drivers for adherence and disease outcomes
in adults (Martin et al., 2011). The nonsignificant result in this study was incongruent to
the results of Lewis (2012) who concluded that it is important for African American men
to have a collaborative relationship with their healthcare provider, which also had a
significant positive influence on their adherence to recommended medications. This
researcher also showed that there is no association between gender and medication
adherence (Lewis, 2012).
In the case of African American men and women, I found that there was no
significant difference between the social support and patient-provider communication
between the two groups. This result was incongruent to those of Ashaye and Giles
(2003), who demonstrated that African American women tend to have a greater
awareness of their condition and are quicker to seek treatment, leading to better blood
pressure control rates. In addition, Lewis et al. (2012) posited that higher rates of
medication nonadherence existed for African American men even in environments with
equal access to care regardless race or socioeconomic status. Despite these previous
findings, the nonsignificant result in this study reflected the notion that there is no
association between gender and medication adherence (see Lewis, 2012). The disparity in
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literature on the role of gender on medication adherence must be comprehensively
researched to provide a consensus for the benefit of researchers and practitioners.
To summarize the interpretation of the findings, in the present study, I provided
support to the notion that patient-provider communication is a predictive variable of
medication adherence of African Americans with hypertension. This offers additional
support to the vital role of trust between patient and provider, especially among
minorities such as African Americans. This entails not only providing more opportunities
for firsthand experiential exercises or practicum experiences, but also ensuring that the
skills development programs deliver quality results for the providers. The nonsignificant
result concerning the role of social support must also be studied further. In addition, I
noted that despite the nonsignificant result, age and gender are critical aspects of
medication adherence that must also be studied.
Limitations of the Study
Despite the significant result, it is important to discuss the findings based on the
limitations that arose throughout the research. One major theoretical limitation in
understanding the results of the present study was the scarcity of recent research focusing
on the relationships of social support, patient-provider communication, and medication
adherence among African Americans with hypertension in the United States. Because of
this, it has been challenging to draw out social psychological and cognitive processes that
occur in this context. Instead, I was only able to identify the explicit relationships and
differences between the independent variables. This can be attributed to the quantitative
nature of the study. Quantitative investigators focus on numbers and analysis to draw
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conclusions about relationships of measured variables. While one of the advantages of
using quantitative methods in the study is that the method can manage data from a large
number of samples, it does not provide insight on underlying theories and processes of a
relationship. Thus, future researchers may select qualitative methods to address this
limitation. This can also help researchers contextualize the disparities in results.
Another limitation can be attributed to the operationalization of variables,
specifically the scales of measure for the independent variables of social support and
patient-provider communication. Nominal scale was used for these independent
variables, which could not account for other aspects such as length of experience, quality
of experience, amount of time spent in the treatment. This could have limited insights and
interpretation on the specific dimensions of each variable and how these can invariably
affect the self-reported medication adherence of the participants. It is important for future
researchers to differentiate different types of social support and various dimensions of
patient-provider communication to further nuance the relationships among the variables.
The sampling method could also be a source of limitation of the study. A total of
493 samples were removed because they did not satisfy the criteria. The use of samples
whose age range from 21 to 65 years old could have limited the analysis in terms of data
saturation. In addition, the use of an age range of 21 to 65 years old as a criterion could
restricted the insights from that could be derived from the data pool. Future researchers
may take note of these sampling limitations and select sampling criteria that are not as
prohibitive.
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To summarize, three major limitations were seen in the present study. The first
limitation was the lack of research on the specific dimensions of these variables and how
they could influence the willingness of African Americans with hypertension to stay
committed to a medication. This impeded the contextualization of the results in the
broader literature on healthcare of racial minorities. The second limitation referred to the
methodology in which nominal scales were used for the independent variables. This
limited the possible in-depth distinction of the influence of social support and patientprovider communication on medication adherence. The third limitation focused more on
the methodology, particularly the sampling method used, which could have hindered indepth interpretation of the results due to the removal of samples. In the next subsection, I
will provide a set of recommendations for future research.
Recommendations
Based on the findings of the study, I recommend that future researchers build
upon the results of this study and conduct studies that analyze specific aspects of each
variable that are related to increased medication adherence in general and in the context
of African Americans with hypertension. For practitioners, it would be interesting to
determine whether family support pushes hypertensive African Americans to seek
medication and stay committed to it, or if peer support is more important. Another
important angle to work on is the quality of relationship between patient and provider—
that is, whether the level of trust between the two parties could have a significant result
on the medication adherence of patients. This could provide a more nuanced
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understanding of medication programs and their impact on the patients’ perceptions and
adherence to medication.
Another important area to investigate is the perception of patients on the level of
social support and quality of relationship that they have with their provider.
Misperceptions and a lack of understanding of the causes and treatment greatly influence
medication adherence as well (Buis et al., 2014). Thus, it is imperative for African
Americans diagnosed with hypertension to adhere to treatment to help lower the burden
of heart disease morbidity and mortality and improve their blood pressure control. It is
also important for healthcare providers to understand the culture of African Americans,
and tailor treatment based on the particular needs of the patient (Brown, 2015). Their
perceptions of these could essentially influence their willingness to adhere to their
medication. Future researchers could investigate this topic by utilizing a qualitative study.
Such type emphasizes how patients perceive their experiences, and these experiences
could affect self-regulatory processes of the patients. Likewise, it would be beneficial for
future researchers to explore the perception of providers on the different factors that
affect their patients’ medication adherence. This could provide comprehensive data on
the relationship among social support, patient-provider communication, and medication
adherence.
To summarize, two important recommendations were discussed: (a) it is
important to further analyze the different aspects of each variable and their association
with medication adherence, and (b) it is critical for future researchers to exhaust every
method possible to understand the perceptions of both patients and providers in the

88
context of hypertension and chronic diseases among ethnic minorities. These
investigations would not only provide additional data but could also improve future
researchers’ nuanced understanding of the different factors that affect the medication
adherence of African Americans. In the next section, I will discuss the implications of the
results for professional practice and social change.
Implications for Professional Practice and Social Change
The present study revealed the explicit relationships among social support,
patient-provider communication, and medication adherence in the context of African
Americans with hypertension in the United States. Specifically, the results showed that
patient-provider communication is a significant predictor of medication adherence among
hypertensive African Americans. This is important especially for researchers to
understand the dynamics of patients and providers and the former’s commitment to
improve their health. The results provide additional context regarding factors that
influence medication adherence and overall healthcare experiences of African Americans
with hypertension. This also entails practical and social implications, which could
possibly contribute to the development of medication programs considering the
effectiveness of patient-provider communication in ensuring the patients’ medication
adherence.
Implications for Professional Practice
Providers are essentially tasked to ensure that the patients trust them enough so
that the latter would adhere to medication. Trust in a provider is synonymous with
adherence to treatment. Patient-provider communication is one way to establish trust and
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encourage individuals to become more involved in decisions regarding their health
(Martin et al., 2011). The results of the study have shown that providers are extremely
influential on the patients’ commitment to medication. As such, it is important for
providers to hone their communication skills in order to build more effective, trust-based
relationships with patients. Central to this relationship is the role of experience. Future
researchers can use the knowledge from this study to develop models that explain
underlying psychological and social processes in the context of medication adherence
among African Americans with hypertension. The findings of the present study
contributed to the theoretical knowledge on the relationships among social support,
patient-provider communication, and medication adherence. The findings may help
substantiate and develop a model that could encompass the different factors that affect
medication adherence of hypertensive patients.
Educational and organizational leaders may apply the insights from this study to
create and maintain programs that develop the communication skills of providers through
providing opportunities for intensive on-the-job experiences and training. This is critical
in ensuring that counselor-in-training will have the chance to apply their knowledge into
practice, while at the same time, increasing their self-efficacy in performing job
responsibilities. Educational and organizational leaders are responsible in developing
policies that highlight the accessibility of medication especially for ethnic minorities such
as African Americans.
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Implications for Social Change
The findings in this study may contribute to positive social change, especially
considering the importance of developing providers’ skills in communication to provide
additional support for hypertensive patients. Previous researchers have suggested that
African Americans are less likely to seek or receive needed health services, procedures,
or routine treatments for hypertension in comparison to White Americans (Martin et al.,
2011). This conclusion was also reflected in the results of this study, in which social
support was not considered a factor in medication adherence of African Americans with
hypertension. Additionally, patients who engage in decision-making with their healthcare
provider are not only more likely to be satisfied with the quality of care but are also likely
to adhere to recommended treatment (Aseltine et al., 2016; Schoenthaler et al., 2009). I
found that the relationship between patient and provider is foundational to ensure
medication adherence among hypertensive African Americans.
This knowledge can be a foundation for policy changes that highlight the role of
provider to provide opportunities for patients to fully understand and appreciate the
importance of medication in improving one’s quality of life. This entails not only
providing more opportunities for firsthand experiential exercises or practicum
experiences, but also ensuring that the skills development programs deliver quality results
for the providers. Additionally, in terms of policies, these results support the need to
reexamine current policies and government programs that focus on the accessibility of
medication for ethnic minorities with chronic diseases. Given the significant role of the
provider, policymakers must revisit current laws and policies on health and well-being to
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ensure that these address the contemporary challenges of racial minority groups with
chronic illnesses. Lastly, the findings of this study demonstrate that improvements in
patient-provider communication and social support can help create social change in
African Americans’ attitudes towards self-management of their health behaviors and
reduce patient isolation in dealing with chronic illnesses including hypertension.
Conclusion
A lack of effective health provider response to uncontrolled blood pressure and
insufficient patient adherence to treatment recommendations create a problem for
hypertensive individuals to maintain their blood pressure. Thus, the purpose of this
quantitative study was to examine the association of social support and patient-provider
communication towards medication adherence for both hypertensive African American
men and women between the ages of 21–65 years in the United States. The results of the
analyses showed that among the three research questions, only Research Question 1
indicated significant results. I found that patient-provider communication is a positive
and significant predictor of medication adherence of African Americans with
hypertension.
Social support, however, was not found to significantly predict medication
adherence. There was also no significant difference on medication adherence by age and
gender. It is critical for researchers to understand the dynamics of patients and providers
and the former’s commitment to improve their health. The results of this study provide
additional context regarding factors that influence medication adherence and overall
healthcare experiences of African Americans with hypertension. Thus, I recommend that
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future scholars focus on a nuanced understanding on the different factors that affect the
medication adherence of African Americans. Policies and skills development programs
must be further enhanced in order to support the critical role of providers in ensuring
medication adherence among African American patients with hypertension.
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